2017 antitrust year in review - wsgr.com · including a high-profile vertical merger challenge by...
TRANSCRIPT
2017 ANTITRUST YEAR IN REVIEW
AUSTIN BEIJING BOSTON BRUSSELS HONG KONG LOS ANGELES NEW YORK PALO ALTO SAN DIEGO SAN FRANCISCO SEATTLE SHANGHAI WASHINGTON, DC WILMINGTON, DE
WSGR 2017 Antitrust Year in Review
Introduction ......................................................................................................................................................... 1
Mergers ............................................................................................................................................................... 2
U.S. Merger Trends ...................................................................................................................................... 2
HSRActEnforcement:ExercisingBeneficialOwnership,FailuretoFile,and Post-HSRClearanceMergerChallenges ................................................................................................ 2
ShiftingApproachtoVerticalMergers ..................................................................................................... 3
CivilLitigationWinsShineSpotlightonDifficultyofMergerDefenses ...................................................... 4
DOJApproachtoEnforcementofMergerSettlements ........................................................................... 5
InternationalInsights ..................................................................................................................................... 5
Europe ................................................................................................................................................... 5
China ..................................................................................................................................................... 7
CivilAgencyInvestigations ................................................................................................................................... 8
U.S.CaseDevelopments ............................................................................................................................. 8
FTCComplaintAgainstQualcommExtendsGlobalDisputeoverLicensingPractices ............................. 8
DOJAnti-SteeringCasesMoveTowardResolution................................................................................. 9
United States v. American Express ................................................................................................... 9
CarolinasHealthCare........................................................................................................................ 9
FTCandDOJContinuetoPursueRestraintsonTradeinHealthcareandHealthProducts
1-800Contacts ................................................................................................................................ 9
OFTACOOP ................................................................................................................................... 10
PayforDelay/ShamPetitions ......................................................................................................... 10
ContinuedDOJ/FTCFocusonInformation-SharingAgreements .......................................................... 10
GuidelinesforHRProfessionals:Information-SharinginLaborMarkets .......................................... 10
DIRECTV ........................................................................................................................................ 11
AmericanGuildofOrganists ........................................................................................................... 11
LouisianaRealEstateAppraisersBoard ......................................................................................... 11
NationalAssociationofAnimalBreeders ........................................................................................ 11
Europe ....................................................................................................................................................... 12
GoogleShoppingandAdSense ........................................................................................................... 12
Intel–DecisionoftheECJ .................................................................................................................... 12
Excessive Pricing ................................................................................................................................. 13
EUAspenPharmaInvestigation ...................................................................................................... 13
UKPharmaceuticalCases .............................................................................................................. 13
“Distribution”Cases ............................................................................................................................. 13
TableofContents
WSGR 2017 Antitrust Year in Review
TableofContents (cont.)
Amazone-Books–MFNClauses ................................................................................................... 13
Coty–SelectiveDistribution ........................................................................................................... 13
LuxuryBrandWatchMakers .......................................................................................................... 14
LithuanianRailwayOperatorCase ........................................................................................................ 14
EUDoubleJeopardy ............................................................................................................................ 14
Criminal ............................................................................................................................................................. 15
NotableDevelopmentsintheDOJ’sCriminalAntitrustEnforcementProgram ............................................. 15
NotableProsecutionsin2017:CorporationsandIndividuals....................................................................... 16
DOJPolicyInitiatives .................................................................................................................................. 19
RevisedLeniencyProgram:FrequentlyAskedQuestions ...................................................................... 19
AntitrustGuidelinesforInternationalEnforcementandCooperation ...................................................... 20
AdvocacyforPerSeStandard ............................................................................................................. 21
AntitrustGuidanceonDisasterReliefEfforts ......................................................................................... 21
GuidelinesforHRProfessionals:CriminalEnforcementforCollusioninLaborMarkets ......................... 21
EnforcementAgainstCollusiveConductOutsidetheU.S. .......................................................................... 21
CivilLitigation .................................................................................................................................................... 24
ThisYearinShermanActSection1and2Litigation ................................................................................... 24
Price-FixingLitigation ........................................................................................................................... 24
MonopolizationandSingle-FirmConductLitigation .............................................................................. 26
ImmunityfromAntitrustLiability ............................................................................................................ 27
TrendsinPharmaceuticalLitigation ............................................................................................................. 28
Pay-for-Delay ....................................................................................................................................... 28
OtherGenericEntryIssues ................................................................................................................... 29
Product-Hopping ........................................................................................................................... 29
RiskEvaluationandMitigationStrategy(REMS) .............................................................................. 30
CitizenPetitions ............................................................................................................................. 30
SovereignImmunity ........................................................................................................................ 30
ClassCertification ....................................................................................................................................... 31
ClassCertificationinPay-for-DelayCases ............................................................................................ 31
IndirectPlaintiffs’FailuretoSurviveClassCertification .......................................................................... 31
DifferentStandardsforAscertainabilityRequirement ............................................................................. 31
Conclusion:Outlookfor2018 ............................................................................................................................ 32
AboutWSGR’sAntitrustPractice ....................................................................................................................... 33
WSGR 2017 Antitrust Year in Review
1
WilsonSonsiniGoodrich&Rosati(WSGR)ispleasedtopresentits2017 Antitrust Year in Review.Inthisreport,wesummarizethemostsignificantantitrustmattersanddevelopmentsofthepastyear.Webeginwithalookatmergersandacquisitions,andwediscusstheshiftswehaveobservedasU.S.agenciestransitionedwiththeTrumpadministration,includingahigh-profileverticalmergerchallengebytheU.S.DepartmentofJustice(DOJ)anda1-1splitbetweencommissionersattheFederalTradeCommission(FTC)thatresultedintheclosingofaninvestigation.WethenexamineinternationalmergersanddiscussnoteworthyshiftsintheEuropeanCommission’spractice.As2017wasanactiveyearforU.S.andEuropeanagencyinvestigations,ourreportdiscussesthe
expandedfocusoncompaniesthathavesignificantintellectualpropertyportfoliosandotherfactorsenforcersviewasanindicatorofdominanceinmarkets.
Inthelasttwosectionsofourreport,wefocusoncriminalcartelandcivillitigationmattersthatimpactedbothU.S.andglobalentities.ThecriminalsectionprovidesanoverviewoftrendsintheDOJ’scriminalenforcementprogram,includingclarificationstoleniencyprogrampolicies,andalowerlevelofoverallcorporatefinesthaninprioryearsastheagencyconcludesmanylargemulti-yearinvestigationsandbeginsseveralnewdomesticandglobalinvestigations.WealsohighlightcartelinvestigationsinactivejurisdictionsoutsideoftheU.S.,includinginCanada,theEU,Japan,Korea,andChina.Finally,inthecivillitigationsection
ofourreport,wediscusskeycasesthatfollowedontheheelsofgovernmentinvestigations,aswellasunilateralconductcasesbroughtbycompetitorsandotherprivateparties.Wedevotespecificattentioninthislitigationsectiontodevelopmentsinthepharmaceuticalsandlifesciencessectors,whichweseeasacontinuingfrontforcomplexandhigh-stakesdisputes.
Wehopeyoufindour2017 Antitrust Year in Reviewtobeausefulresourceonthemostmeaningfuldevelopmentsfromthepastyear.Asalways,shouldyouhaveanyquestionsorcommentsonanyofthematters,trends,orcontroversiesdiscussedinthereport,pleasecontactyourregularWSGRattorneyoranymemberofthefirm’santitrustpractice.
Introduction
WSGR 2017 Antitrust Year in Review
2
Mergers
U.S. Merger TrendsAntitrustenforcementgenerallyisbipartisan,withoutdramaticswingsineitherpoliticaldirection.Enforcementdecisionsarebasedonfacts,economics,andthelaw—andultimately,whenlitigated,determinedbythecourts.Still,withincreasedpublicattentionfocusedonantitrustenforcement,thishasbeenanareatowatchastheFederalTradeCommission(FTC)andtheAntitrustDivisionoftheU.S.DepartmentofJustice(DOJ)(collectively,theagencies)transitionedunderanewRepublicanadministration.
In2017,PresidentTrumpannouncedhisnomineestoleadtheAntitrustDivisionoftheDOJandtheFTC.TheSenateconfirmedPresidentTrump’spick,MakanDelrahim,astheAssistantAttorneyGeneral(AAG)fortheAntitrustDivisiononSeptember27,2017.1DelrahimwasaDOJofficialintheBushAdministrationandservedintheTrumpWhiteHouseuntilhisconfirmationasAAG.ThenewDOJleadershiphasalreadymadeitsmark,challengingAT&T’sacquisitionofTimeWarner.ThetrialisscheduledforMarch2018.ThelawsuitcameontheheelsoftheDOJ’sannouncementthattheagencygenerallyisnolongeramenabletomergersettlementsunlessthoseresolutionsinvolvesellingoffalineofbusinessthatisthesourceofthecompetitionconcerns.
AttheFTC—abipartisan,five-personcommission2—PresidentTrumphasnominatedJosephSimons(aRepublican)asFTCChairman,3aswellasNoahPhillips(aRepublican)andRohitChopra(aDemocrat)asFTCCommissioners.4 UntilthesenomineesareconfirmedbytheU.S.Senatesometimein2018,theFTCwillcontinuetobeledbytwo
commissioners—ActingChairmanMaureenOhlhausen(aRepublican)andCommissionerTerrellMcSweeny(aDemocrat),bothofwhomneedtovoteinfavorofanenforcementactioninordertosuetoblockatransaction.
TheFTC’s1-1splitisunprecedented,andtheFTC’sreviewofWalgreensBootsAlliance’s(Walgreens)acquisitionofRiteAidstoresshowshowthisunusualscenariocanplayout.OnOctober27,2015,WalgreensannounceditsintentiontoacquirecompetingretailpharmacyRite Aid.5Inearly2017,afteranin-depthinvestigationbytheFTC,Walgreensofferedtosell865drugstorestoFred’sInc.inordertoresolvetheFTC’santitrustconcerns.6Thepartiescouldnotobtaintherequiredunanimousvotetoapprovethesettlement,and,attheendofJune,thecompaniesabandonedtheinitialtransaction.7Walgreensthenproposedanewtransactionthroughwhichitwouldacquireonly2,186(orfewerthanhalfof)RiteAid’sstores,whichwasalsorejected.WalgreensultimatelysatisfiedActingChairmanOhlhausen’sconcernsbypurchasingonly1,932stores.8Thisrevisedtransactionwasclearedwithoutfurtherinvestigation.CommissionerMcSweenyissuedastatementexpressingherdisappointmentabouttheresult,sayingthatataminimum,theFTCshouldhavefullyexaminedthereviseddeal.9 Acting ChairmanOhlhausenissuedherownstatement,statingthatthoseconcernswereunfounded.10BecauseActingChairmanOhlhausenhasthesoleauthoritytodeterminewhethertoconductaninvestigation,whenshedeclinedtolaunchsuchaninvestigation,thedealclosed.
Inspiteofthissplit,theFTCmaintainsthatitisbusinessasusualduringthetransitionperiod.11Bothcommissionersvoted
togetherinfavorofchallengingtwootherproposedtransactions.12Nevertheless,untilthereisafullcomplementofFTCcommissionersin2018,asinglecommissioner’svotecan,asitdidintheWalgreens/Rite Aidcase,resultinnoaction.
HSR Act Enforcement: Exercising Beneficial Ownership, Failure to File, and Post-HSR Clearance Merger Challenges
TheHart-Scott-RodinoImprovementsActof1976(HSRAct)mandatesthattransactionsthatmeetspecificthresholdsbenotifiedtotheantitrustagenciesforreview.If,aftera30-daywaitingperiod,therelevantagencystillhasdoubtsaboutthecompetitiveeffectsofthenotifiedtransaction,theagencywillissueaRequestforAdditionalInformationandDocumentaryMaterials(knownasaSecondRequest),openinganin-depthreviewintothetransaction.TheFTCandDOJ’srecentlyreleasedFY2016AnnualHSRReport13showedthatbothfilingsandSecondRequestsincreasedoverFY2015.14
ThedeterminationofwhetheratransactionrequiresafilingundertheHSRAct—andtherestrictionsthatapplytocompaniesduringtheHSRwaitingperiod—isimportant.TheagencieswillbringenforcementactionsagainstcompaniesandindividualsforHSRActviolations,and2017wasnodifferentinthatrespect.
InJanuary2017,theDOJannouncedanenforcementactionagainstDukeEnergyCorporation(Duke)for“gun-jumping”inconnectionwithitsacquisitionofOspreyEnergyCenter(Osprey).15UndertheHSRAct,acquirersmaynotobtainbeneficialownershipoftheacquiredcompany’s
WSGR 2017 Antitrust Year in Review
3
assetsorvotingsecuritiesduringtheHSRwaitingperiod.Apartymaybeviewedasprematurelyobtainingbeneficialownershipofabusiness(orengageingun-jumping)byassumingtheriskorpotentialbenefitofchangesinthevalueofthebusinessorexercisingcontroloverday-to-daybusinessdecisions.Inthiscase,theDOJallegedthatDukeenteredintoatollingagreementthatimmediatelygaveDukecontroloverOsprey’soutputaswellastherighttoreceiveday-to-dayprofitsandlossesfromOsprey’sbusiness,therebyremovingOspreyasanindependentcompetitor,beforeexpirationoftheHSRwaitingperiod.16Dukeagreedtopay$600,000toresolvetheDOJ’scomplaint.17
Theagenciesalsopursuedtwofailure-to-filecasesin2017.InApril2017,entrepreneurMitchellP.Ralesagreedtopay$720,000toresolvechargesthatheviolatedtheHSRAct18byfailingtoreporthispurchasesofsharesinamountsabovetheapplicablefilingthresholdswhenheandhiswifepurchasedsharesinColfaxCorporationandDanaherCorporationin2008and2011.19Ralescontendedthattheviolationswereinadvertent,buttheFTC,inseekingpenalties,notedthatRaleshadpaidcivilpenaltiestosettleanHSRenforcementactionin1991.20AlsoinApril,hedgefundfounderAhmetH.Okumusagreedtopay$180,00021toresolvechargesthatheviolatedtheHSRActbyfailingtoreporthispurchasesofvotingsecuritiesinWeb.comGroupInc.,aninternetservicescompany.22PurchasersshouldbemindfuloftheHSRrulesthatrequireafilingfortransactionsresultinginthevalueofthepurchaser’svotingsecuritiesexceedingannuallyadjustedvaluethresholds.ItisimportanttoseekcounseltodeterminewhetheranHSRfilingisrequired.
Asageneralmatter,oncepartiescleartheHSRwaitingperiod,theycanclosetheirtransactionwithoutexpectingtheagencieswillchallengetheirtransaction—butnot
always.OnSeptember26,2017,theDOJfiledsuitagainstindustrialequipmentmanufacturerParker-Hannifin,lookingtopartiallyunwinditsconsummated$4.3billionacquisitionofrivalCLARCOR.23ThepartiesannouncedtheirtransactiononDecember1,2016,andParker’spublicfilingsindicatethattheHSRwaitingperiodexpiredonJanuary17,2017,withoutaSecondRequestforinformation.24TheDOJthenreceivedacomplaintaboutthetransactionandopenedaninvestigation,ultimatelysuingtoblockthedeal.25 In apressreleaseregardingitscomplaint,theDOJstatedthat“Parker-Hannifinfailedtoprovidesignificantdocumentordataproductionsinresponsetothedepartment’srequests”anddidnotenterintoa“satisfactoryagreementtoholdseparatethefuelfiltrationbusinessesatissueandtomaintaintheirindependentviabilitypendingtheoutcomeoftheinvestigation.”26Parker-HannifinlateragreedwiththeDOJ,insettlingthecase,todivesttheaviationfuelfiltrationbusinesstoresolvetheagencies’concerns,aninsignificantpartofthe$4.3billiondeal.27 WhiletheDOJalwayshasmadeclearthatitcanandwillchallengemergersthatdonotrequireanHSRfiling,itismoreunusualforittochallengeatransactionthathadalreadyclearedagencyreview.Thiscasemayultimatelyprovetobeanoutlier;however,itisareminderthatbothagencieshavebroadpowerstochallengeanytransaction.
Shifting Approach to Vertical Mergers
Transactionsinvolvingbusinessesoperatingatdifferentlevelsofasupplychain(verticaltransactions)areanareatowatch,withtheAT&T/Time Warnertrialinthespotlightin2018.Verticalmergersdonoteliminatehead-to-headrivalrybetweenexistingfirms,butoftenhelpfirmsalignincentivesandreducecosts—andhavegenerallybeenviewedasofferingatleastsomeefficienciesthatbenefit
companiesandimportantly,consumers.Antitrustagencieshave,generally,resolvedcompetitiveconcernsinverticalmergers,throughbehavioraldecreesthatenablethetransactiontoproceedwhiletargetingspecificconductthatisthesourceofpotentialcompetitiveharm.TheDOJ’sRemedyGuideissuedin2010statesthatbehavioralremediesmaybeavaluabletoolinalleviatingcompetitiveharmthatmayresultfromamergerwhilepreservingitspotentialefficiencies.28 Forexample,wheretheagencieshaveaconcernaboutthemergedentitywithholdingacquiredassetsfromrivals,transactingpartiesmayberequiredtocontinuetolicenseorselltheirproductstothirdparties.Themergedcompanymayalsoberequiredtoestablishfirewallsthatpreventthesharingandmisuseofinformationnewlyaccessibleasaresultofthetransaction.
Inanotabledeparture,inoneofhisfirstspeechesasAAG,MakanDelrahimexpressedhissignificantskepticismaboutbehavioralremedies,describingthemas“overlyintrusiveandundulyburdensomeforbothbusinessesandgovernment.”29 HenotedthattheDOJwill“returntothepreferredfocusonstructuralrelieftoremedymergersthatviolatethelawandharmtheAmericanconsumer.”30
Fourdayslater,onNovember20,2017,theDOJfiledacomplaintchallengingAT&T’sproposedacquisitionofTimeWarner—averticalmergercombiningAT&T’svideodistributionbusinesswithTimeWarner’scontentbusiness.31TheDOJ’scomplaintallegesthatAT&T,adistributorofcontent,willhavetheincentivetowithholdTimeWarner’scontentfromitsvideodistributioncompetitors.32TheanswerfiledbyAT&TandTimeWarnernotesthatTimeWarner“formallyandirrevocably”offeredthird-partydistributorslicensingtermssimilartothoseacceptedbytheDOJin2010whenitconsideredasimilarverticaltransactionthatcombinedComcast
WSGR 2017 Antitrust Year in Review
4
andNBCUniversal.33Thecaseremainsongoing,and,inthenearterm,thereislikelylittleroomforthepartiestoproposeconduct-focusedsettlementstotheDOJ.
ItisunclearwhethertheFTCwilltakeasimilarapproach.InJuly,theFTCacceptedabehavioraldecreetoremedyconcernsthatBroadcom’sacquisitionofBrocadeCommunicationsSystemswasanticompetitive.34Pursuanttothedecree,BroadcomagreedtosetupafirewalltopreventtheexchangeofCiscoSystems’confidentialbusinessinformationtoBrocade.35IftheFTCcontinuestobeamenabletobehavioralremediesin2018,thefateofpotentiallyproblematicverticalmergersmayhinge,inpart,onwhethertheFTCortheDOJreviewsthedeal.
Behavioralremediesalsohaveattractedattentionmorebroadly.InDecember2017,U.S.SenatorElizabethWarrendeliveredaspeechattheOpenMarketsInstitutecallingformoreaggressiveantitrustenforcementandcommendingtheDOJ’ssuitagainstAT&TandTimeWarner.36SenatorWarrennotedspecificallythatinorder“torevivecompetitioninoureconomy,verticalmergers,particularlymergersinalreadyconcentratedindustries,shouldbeviewedwiththesamecriticaleyethat’sneededformergersbetweendirectcompetitors.”37SenatorWarren’sremarksalsocalledouttechcompaniesspecifically,warningthatthereis“noexceptioninantitrustlawsforbigtech.”38
Civil Litigation Wins Shine Spotlight on Difficulty of Merger Defenses
Thisyear,theagenciesaddedtotheirmergerlitigationrecords,includingtheDOJ’ssuccessfullitigationofthreemajormergersin2017—twomergersinthehealthinsuranceindustryandEnergySolutions’acquisitionofWasteControlSpecialists.
Inlate2016,theDOJ,11states,andtheDistrictofColumbiasuedinfederaldistrictcourttoblockthe$54billiondollarcombinationofhealthinsurersAnthemandCigna.39ThecourtenjoinedthismergerinFebruary2017,findingharmintwooftheallegedfivemarketswherethegovernmentallegedharm,includinginthesaleofhealthinsuranceandthepurchaseofhealthcareservicesbycommercialhealthinsurers.40 AdividedpaneloftheU.S.CourtofAppealsfortheD.C.CircuitaffirmedthisdecisioninApril,findingthatcompetitiveharmforthesameofhealthinsurancetonationalaccountssufficedtoenjointhemergerandthatthecompaniesefficienciesclaimsfailedtooffsetthelikelyharmfromthemerger.41OnMay12,2017,AnthemannouncedthatitwouldnolongerseektoacquireCigna.42
InanothercasefiledthesamedayastheAnthem/Cignachallenge,theDOJ,eightstates,andtheDistrictofColumbiachallengedthe$37billionmergerofAetnaandHumana,allegingtheeliminationofcompetitioninboththesaleofhealthinsuranceandthepurchaseofhealthcareservices.43TheDOJ’scomplaintallegedthatthetwomergers“wouldreshapetheindustry,eliminatingtwoinnovativecompetitors...atatimewhentheindustryisexperimentingwithnewwaystolowerhealthcarecosts.”44 In January2017,theU.S.DistrictCourtfortheDistrictofColumbiasidedwiththeDOJ.45InFebruary,AetnaabandonedthetransactionandpaidHumana$1billioninbreak-upfees.46
Anthem/Cignamaybethemoreinstructivecasebecauseitservestoremindpartiesthatitisdifficulttoproveinlitigationthatanticompetitiveeffectsmaybeovercomebyefficiencies.Agenciesgenerallyrecognizethatevenmergersofhead-to-headcompetitorscanleadtoefficienciesthatresultinlowerprices,qualityimprovements,andinnovation.
Indeed,transactionsareoftenclearedonthebasisofsuchefficiencies.However,inlitigation,partiesaremuchlesssuccessfulinpersuadingcourtsoftheseefficiencies.In Anthem,thepartiesarguedthatthecombinationwouldgenerate$2.4billioninmerger-specificefficienciesonanannualbasisandthatthemergerwouldresultinreducedprovidercoststhatwouldmakehealthcaremoreaffordableforcustomers.47Thedistrictcourtdisagreed,decliningtocredittheclaimedefficiencies,andAnthemappealedthisissuetotheD.C. Circuit.48Themajorityopinionofthethree-judgepanelsidedwiththeDOJandthestates,questioning(butnotresolving)theavailabilityofanefficienciesdefenseinthecontextofanillegalmerger,49andholdingthatevenwithsuchadefense,Anthemfailedtorebutthegovernment’scase.50Theappellatecourtagreedwiththelowercourt’sholdingthat,amongotherthings,theefficiencieswerenotmerger-specific,werevagueandnotverifiable,andwouldnotbepassedthroughtoconsumersattherateclaimedbytheparties.51
Another2017DOJlitigationwinrevealsanotherdifficultmergerdefense—thefailingfirmdefense.InJune2017,theDistrictofDelawareruledinfavoroftheDOJintheagency’schallengetoanacquisitionbyEnergySolutionsofWasteControlSpecialists(WCS),bothofwhichprovideradioactivewastedisposaltocommercialcustomers.52TheDOJallegedthatthetransactionwouldbeamergertomonopolyinonemarket.Thedefendantsassertedafailingfirmdefense,whichispermittedwhen“thepossiblethreattocompetitionresultingfromanacquisitionisdeemedpreferabletotheadverseimpactoncompetitionandotherlossesifthecompanygoesoutofbusiness.”53 However,thecourtinthecaseexplainedthatdefendantsmustshow:“(1)thattheresourcesof[WCS]were“sodepletedand
WSGR 2017 Antitrust Year in Review
5
theprospectofrehabilitationsoremotethatitfacedthegraveprobabilityofabusinessfailure,”and(2)thattherewasnootherprospectivepurchaserforit.”54
ThecourtultimatelyrejectedfailingfirmdefensebecausethedefendantsfailedtodemonstratethatEnergySolutionswasthe“onlyavailablepurchaser”ofWCS.55Inthiscase,thecourtfoundtherewasnogoodfaithefforttofindotherreasonableoffers.Instead,theparentcompany“essentiallyengagedinasinglebidderprocess”andthenreliedondealprotectiondevicesthatmadeitimpossibletoentertainotheroffers.56Thecourtruledinfavorofthegovernmentandenjoinedthe$367millionmerger.57 EnergySolutions/WCSshowsnotonlythehighburdentoestablishthattheacquiredcompanyisingraveprobabilitya“businessfailure,”butalsotheneedtocarefullyevaluatetheapproachtosellingassetsifafailingfirmdefensewillbeadvanced.
DOJ Approach to Enforcement of Merger Settlements
TheDOJ’smergersettlementsalsoofferguidepostsforpartiesanalyzingantitrustrisk.InJune2017,GeneralElectric(GE)reachedasettlementwiththeDOJ,agreeingtodivestitsWaterandProcessTechnologies(GEWater)toSUEZS.A.bytheendofSeptember2017,asaconditiontoacquiringBakerHughes.58AlthoughGEdivestedassetsaccountingfor90percentofGEWater’srevenues,asofOctober2017,ithadnotyettransferredlegaltitleofcertainGEWaterassetsincertaininternationaljurisdictions,andinformedtheDOJthatadministrativehurdleswouldlikelydelaycompletionofthedivestmentinto2018.59Inresponse,theDOJandGEenteredamodifiedfinaljudgmentwherebyGEagreed:(1)tomakedaily“incentivepayments”totheDOJforeachdayin2018thatthedivestitureisnotfullycompleted;and(2)toreimbursetheU.S.forattorney’sfeesandcostsincurred
inaddressingdelaysandenforcingtheoriginalconsentdecree60—featuresthat,accordingtotheDOJ,wouldbecomemoreregularcomponentsofconsentdecreesmovingforward.61
Inanothercase,theDOJ’sconsentdecreerelaxedthestandardforanysubsequentcontemptactionforfailuretocomplywithsettlementterms.InCBS/Entercom, theDOJrequiredEntercomtodivest13radiostationsinthreecitiestoprotectcompetitionforlocalbusinessesthatsoughttoadvertiseonradiostationsinthoseparticularmarkets.62Typically,acivilcontemptactionmustbeprovenbyaclearandconvincingevidencestandard,63 butunderthetermsoftheCBS/Entercom decree,anyallegedviolationbythepartieswillbeevaluatedundera“preponderanceoftheevidence”standard.64
InlightoftheGEandEntercomsettlements,partiesshouldthinkcarefullyaboutalltermsinaDOJmergersettlementandidentifyanyareasinadvancewherecompliancemaybedifficult.TheDOJmaynotbeflexibleinamendingorextendingsuchtermsonceasettlementhasbeenreached.
InternationalInsightsEurope
Focus on Innovation in Merger Reviews
ThemergerbetweenE.I.duPontdeNemoursandCompany(DuPont)andtheDowChemicalCompanywasconditionallyapprovedbytheEuropeanCommission(EC)onMarch27,2017.65ItwasthefirstofatrioofmegadealsintheagrichemicalsindustrytoobtainclearanceinEuropethisyear.TheECanalyzedwhetherthecombinationmightreducecompetitionwithrespecttocropprotection(pesticides)andsomepetrochemicals,focusingonconcernsthatthemergerwouldreducetheparties’incentivetocompetethrough
innovation.ThemergerwasultimatelyapprovedafterthepartiessubmittedcommitmentstodivestasignificantpartofDuPont’sexistingpesticidebusinessincludingitsR&Dbranch.Thesecondmergerinthetrio,ChemChina/Syngenta, wasconditionallyapprovedbytheEConApril5,2017,basedonaseriesofdivestituresofferedbyChemChinaintheirAdamaandSyngentaproductswithinthepesticideandplantgrowthmarkets.66Inthiscase,theECconsidered,butultimatelydismissed,theconcernthatcompetitionforinnovationwouldbeimpacted.67
Thethirdagrichemicaldealisstillpending.AfterrejectingPhaseIcommitmentssubmittedbytheparties,theECannouncedinAugust2017thatitwasopeninganin-depthinvestigationintotheproposedacquisitionofMonsantobyBayer,adiversifiedGermanpharmaceuticals,consumerhealth,agriculture,andanimalhealthcompany.68 Ifapproved,thetransactionwillleadtothecreationofthelargestintegratedcompanyintheindustry,withthelargestportfolioofpesticideproductsandapowerfulglobalmarketpositioninthemarketsforseedsandtraits(plantcharacteristicssuchasheight,herbicidetolerance,andinsectresistance,whichcanbedevelopedinlaboratoriesandintroducedintocertainplantvarieties).TheEC’spreliminaryconcernsarethattherecouldbeareductionofcompetitioninthemarketsforpesticides,seedsandtraits,leadingtohigherprices,lowerquality,lesschoice,andlessinnovation.Critically,however,theECisalsoinvestigatingwhethercompetitors’accesstodistributorsandfarmerscouldbecomemoredifficultifBayerandMonsantoweretobundleortietheirsalesofpesticideproductsandseeds,notablewiththeadventofdigitalagriculture,withsignificantinvestmentbyBayerandMonsanto.Digitalagricultureinvolvesthecollectionofdataand
WSGR 2017 Antitrust Year in Review
6
informationaboutfarmstoprovidefarmerswithtailoredadviceoraggregateddata.TheEChasuntilMarch5,2018,tomakeadecision.69
WhiletheEChaslookedattherelationshipbetweenpipelineproductsandproductsonthemarketinanumberofpharmaceuticalmergers,theemphasisoninnovationinanindustry,ratherthaninaspecificantitrustmarket,isnewandcontroversial.CommissionerforCompetitionMargretheVestagerseemsdeterminedtoexplorethisarea.Shehasmadeseveralhigh-profilespeechesthisyearfocusingontheimportanceofinnovationforthecompetitiveprocess,andcaseteamsarenowsystematicallytestingtheincentivestoinnovateinmergerinvestigations.70
Penalties Imposed for Procedural Violations
Gun-Jumping
Thisyear,theECsentseparateStatementsofObjectionstotwocompanies,telecommunicationscompanyAlticeandimagingequipmentmanufacturerCanon,forallegedgun-jumping.Theseactionswereinlinewithageneraltrendofincreasedenforcementinthisareaacrosstheglobe.
InFebruary2015,AlticenotifiedtheECofitsintentiontoacquirecontrolofPortugal’slegacytelecomsoperator,PTPortugal.InaStatementsofObjectionsissuedtothecompanyinMay2017,theECtakesthepreliminaryviewthatthroughaseriesofactions,AlticeimplementedtheacquisitionpriortotheadoptionoftheEC’sclearancedecision,andinsomeinstances,priortoitsnotification.71Inparticular,theECallegesthatthepurchaseagreementbetweenthetwocompaniesputAlticeinapositiontoexercisedecisiveinfluenceoverPTPortugalbeforenotificationofthetransaction,andthatincertaininstances
AlticeactuallyexerciseddecisiveinfluenceoverPTPortugal.72ThisisnotthefirsttimeAlticehasbeeninvolvedinagun-jumpinginvestigation.InNovember2016,Alticewasfinedarecord-breaking€80million($88million)forgun-jumpingbytheFrenchnationalcompetitionauthority.73 An EC officialsaidataconferenceinOctober2017thattheECisanalyzingcarefullythecovenantsinthesharepurchaseagreement,andthetypeofrightsthatweregrantedtothepurchaserbetweensigningandclosing.74
Intheothergun-jumpinginvestigation,theECislookingintoCanon’sacquisitionofToshibaMedicalSystemsCorporation(TMS).TheEC’spreliminaryconclusionisthatCanonacquiredTMSbywayofatwo-steptransactionstructureinvolvinganinterimbuyer,whichessentiallyallowedittoacquirecontrolofTMSpriortoobtainingmergerapproval.75 In Canon/TMS,asafirststep,theinterimbuyeracquired95percentofthesharecapitalofTMSfor€800(approximately$940),whereasCanonpaid€5.28billion(approximately$6.2billion)forboththeremaining5percentandshareoptionsovertheinterimbuyer’sstake.ThisfirststepwascarriedoutpriortonotificationtotheEC.Asasecondstep,followingapprovalofthemergerbytheEC,theshareoptionswereexercisedbyCanon,givingitcontrolover100percentofthesharesofTMS.76
Asmergerproceduresinmanymajortransactionsbecomelonger,mergingpartiesareconstantlyexploringtheboundarieswithinwhichtheyarepermittedtoworktogetherpriortoclosing.TheAlticecasemayultimatelyprovideclarityonwhatpre-closingcovenantstheECconsidersunacceptable,whiletheCanoncasemayprovideimportantguidanceonhowtheECviewstransactionsstructuredinstages.However,ifmergingpartieswerehopingforguidancefromtheGeneralCourt (GC) in Marine Harvest/Morpol,
thishasnotbeenparticularlyfavorable.InOctober2017,theGCdismissedtheappealfiledbyaNorwegianseafoodcompany,MarineHarvest,againsta€20million(approximately$25.3million)gun-jumpingfinein2014—thefirstofitskindimposedbytheEC.77WhiletheGCacknowledgedthatthecompletetakeoverofMorpol,aNorwegiansalmonproducer,occurredinthreestagesinvolvingvarioussellers,itagreedwiththeECthatMarineHarvesthadacquireddefactosolecontroloverMorpolduringthefirststepofthetransaction,andthatthenotificationobligationwastriggeredatthatstage.78
Providing Misleading Information
Focusingonotherproceduralbreaches,inMay2017,theECfinedFacebook€110million(approximately$122million)forprovidingmisleadinginformationduringits2014reviewofFacebook’stakeoverofWhatsApp, anunprecedentedfineforsuchinfringements.79DuringtheEC’sreview,Facebookhadexplainedthattheautomatedmatchingbetweenthetwocompanies’useraccountswasnotyetreliableandwasinfactimpracticable.80 Twoyearslater,Facebook’stermsofserviceandprivacypolicyevidencedthattheautomatedmatchingbetweentheseparateaccountshadinfactbeenachieved.TheECreactedbysendingFacebookaStatementofObjectionsallegingthat,contrarytoFacebook’ssubmissionsduringthemergernotificationprocess,automatedmatchingwasalready arealityatthattimeandFacebook’sexpertswereawareofit.TheECfinedFacebooklessthanthemaximumfineof1percentofitsaggregateturnover,butthefinecouldhavebeenhigherhadFacebooknotcooperatedfullywiththeEC’sinvestigation.81Announcingthefineinapressrelease,CommissionerVestagerreiteratedherviewthatevenbreachesofthemergercontrolproceduralruleswillnotbetolerated:“Today’sdecisionsends
WSGR 2017 Antitrust Year in Review
7
aclearsignaltocompaniesthattheymustcomplywithallaspectsofEUmergerrules,includingtheobligationtoprovidecorrectinformation.”82
TheECalsosentaStatementofObjectionstoMerckthisyear,forallegedly(intentionallyornegligently)supplyingincorrectormisleadinginformation.InJune2015,theECclearedtheMerck/Sigma-Aldrichmerger,providedthemergingpartiesdivestedcertainSigma-Aldrichassets.83Merckhadnotdisclosedtheexistenceofanimportantinnovationprojectconcerningcertainlaboratorychemicals,whichwouldhavebeenrelevanttotheEC’sassessment.Subsequently,theECwasmadeawareofthisbyathirdparty.HadtheR&DprojectbeendisclosedtotheEC,theremedypackagewould,itisalleged,haveincludedit.Therelevantinnovationwascloselylinkedtothedivestedbusinessandhadthepotentialtosubstantiallyincreaseitssales.Bynotincludingit,theviabilityandcompetitivenessofthedivestedbusinesswasimpaired.AlthoughMerckhassinceagreedtolicensetherelevanttechnologytoHoneywell—thebuyerofthedivestedbusiness—thishappenedalmostoneyearafterthedivestment.84
Similarly,thisyeartheECopenedaninvestigationregardingallegationsthatGEprovidedmisleadinginformation.AccordingtotheEC’sallegations,whentheagencyfirstreviewedGE’sacquisitionofLMWind,GEhadfailedtodiscloseinformationtotheECconcerningitsR&Dactivitiesandthedevelopmentofaspecificproduct,whichwereimportanttotheEC’sassessmentofGE’spositionontheonshoreandoffshorewindturbinemarkets.TheECviewedthisomissionascriticalnotonlytothistransaction,butalsototheEC’sassessmentofSiemens’acquisitionofGamesa,aseparatetransactioninthewindturbinemarket,beingreviewedatthesametime.The
EChasstatedthattheinformationwasnecessarytoproperlyassess,inbothcases,thefuturepositionofGEandthecompetitivelandscapeonthemarketsforwindturbines.GEwithdrewitsnotificationandre-filed,includingtherelevantinformationinthesecondfiling,andissuedapublicstatementthatithadnointenttomisleadtheEC.Notwithstandingbothmergers (GE/LM WindandSiemens/Gamesa)beingclearedunconditionallyinMarch2017,GEisnowfacingtheprospectofaproceduralfine.85
TheEC’srecentpushonproceduralbreachinvestigationshasnothadanimpactontheEC’sdecisionsapprovingthoseparticularmergers,whichremaineffective.ThefactthattheECisusingitsresourcestopursuecompanieswherethoseinvestigationsdonothaveanimpactontheoutcomeofthemergerapprovalshighlightstheEC’stoughstanceonproceduralbreachesandservesasaremindertobusinessesthattheECcanrevokeaclearancedecisionifitisbasedonincorrectinformationforwhichoneofthemergingfirmsisresponsible.
EC’s Ongoing Consultation on Merger Control Thresholds
In2017,theECconsultedonplanstomodifytherulesthattriggeramandatoryfilingwiththeECtocatchtransactions,whicharelikelytohaveanimpactintheEuropeanmarket,butdonottriggerthecurrentturnover-basedthresholds.Anychangeislikelytobeparticularlysignificantforthedigitalandpharmaceuticalindustries,wherethetargetcompanymayhavemodestsalesinEurope,butholdcommerciallyvaluabledata,orhaveconsiderablemarketpotentialforotherreasons.86Forexample,indigitalmarkets,manycompanies’businessmodelinvolvestheownershipandcurationofdataanduserrelationships,whichwillonlybemonetizedsubsequently.Since
manysuchbusinessesdonotnecessarilygeneratesignificantturnoverintheirfirstfewyears,theirsalesmayfallbelowthecurrentmergercontrolregimethresholds.GiventheEC’sfocusonpreventingmergersthatmightharminnovationinthefuture,achangeinthejurisdictionalthresholdswouldprovidetheECwithanadditionaltooltoreviewmergersthatarenotcaughtunderthecurrentrules,butwhichtheECconsidersmayhaveanimpactoncompetition.TheECpublishedasummaryoftherepliestoitsconsultationinJuly2017,87butasofthedateofthispublication,noevaluationhasyetbeenmadepublic.
China
In2017,China’sMinistryofCommerce(MOFCOM)issuedanumberofconditionalapprovaldecisionsforlargeinternationalmergersrequiringtheirclearance,bothstructuralandbehavioral.Forexample,inAugust2017,Broadcom’stakeoverofBrocadeCommunicationsSystemsreceivedapprovalfromMOFCOMontheconditionthatBroadcommaintaintheinteroperabilitybetweenitsownswitchesandthirdpartyhostbusadapters(HBAs), andneverdiscriminateagainstthird-partyHBAs.88ThecompanywasalsorequiredtoinstallfirewallsakintothoserequiredbytheU.S.andEuropeanagencies,andtorefrainfromengaginginanytie-insaleorbundlinginanyform.89Likewise,inMay2017,MOFCOMgrantedregulatoryapprovalofDuPontandtheDowChemicalCompany’sproposedmerger,conditionedonDuPontandDowdivestingcertainpartsofDuPont’scropprotectionportfolio,itsR&Dpipelineandorganization,andDow’sglobalethyleneacrylicacidcopolymersandionomersbusinesses.90
TheChineseauthoritiesalsoissuedanumberofproceduralfinesthisyearforcompanies’failurestonotifytransactions.91 OneimportantdeparturefortheChinese
WSGR 2017 Antitrust Year in Review
8
authoritiescameonJanuary4,2017,whenMOFCOMpublisheditsdecisiontofineJapanesefirmCanonInc.forfailuretonotify,underChina’sAnti-MonopolyLaw(AML),itsacquisitionofToshibaMedicalSystemsCorporation,aJapanesemedicalequipmentcompany,fromToshibaCorporationinatwo-stepmerger.92 MOFCOM—liketheEC—essentiallyregardedbothstepsofthetransactionaspartofthesametransactionandconcludedthatCanonshouldhavenotifiedthetransactionbeforecompletionofthefirststepofthemerger.Failuretodoso,accordingtoMOFCOM,meantthatCanon
hadjumpedtheguninimplementingatleastpartsofthetransactionbeforeobtainingMOFCOMclearance.MOFCOMfinedCanonRMB300,000(approximately$43,000)foritsfailuretonotify,despitethefactthatthetransactionraisednosubstantivecompetitionconcerns.93
OnSeptember8,2017,MOFCOMpublishedreviseddraftmergerreviewmeasures,whichwillamendChina’sAML,forpubliccomment.94Itisexpectedthatsomeamendmentswillbemadeinordertosupplementandclarifythecurrentlaw,forexample,clarifyingtherules’
conceptof“control.”95Inaddition,thedraftmeasuresclarifythelaw’streatmentofinter-dependenttransactions;makesomechangesregardingthecalculationofturnoverinthecaseofathresholdsanalysis;andsetoutanewprocedureforMOFCOMtoinvestigatenon-reportabletransactionsthatdonotmeetthestatutorythresholds.96Notably,ithasalsobeenproposedthatthestatutorypenaltyforfailuretonotifyanotifiableconcentration,currentlycappedatRMB500,000(approximately$76,000)wouldbeincreased.97
Antitrustagenciesworldwidelaunchedinvestigationsintonewareasofallegedlyanticompetitivebehaviorin2017,whilecontinuingtofocusonprioritiessetinpreviousyears.IntheU.S.,theFederalTradeCommission(FTC)joinedotherjurisdictionsinlaunchingasuitagainstQualcommoveritssmartphoneIPlicensingpractices,whiletheU.S.DepartmentofJustice(DOJ)continuedtopursueitslandmarkcreditcardanti-steeringcasedespiteasetbackattheCircuitCourtlevel.TheU.S.agenciesalsodrilleddeeperintoinformation-sharingandotherallegedlycollusivepractices,particularlyinkeyindustries—likehealthcare—thatarethesubjectofheightenedconcernsoverconsumerwelfare.
InEurope,commissionenforcerssawamajorsetbackwiththeEuropeanCourtofJustice’s(ECJ’s)reversaloftheEuropeanCommission’s(EC’s)previousdecisionagainstIntel.Googlewasalsointhespotlight,withtheECissuingahistoric€2.42billion(approximately$2.91
billion)fineinthelong-runningShoppingcasewhilecontinuingsimultaneousinvestigationsintoGoogle’sAdSenseandAndroidpractices.Beyondthetechsector,theECalsocontinuedtobreaknewgroundthroughinvestigationsintoavarietyofallegedlyharmfulunilateralpractices,includingexcessivepricing,MFNdistribution,andunilateralrefusalstodeal.
U.S.CaseDevelopmentsFTC Complaint Against Qualcomm Extends Global Dispute over Licensing Practices
OnJanuary17,2017,theFTCvoted2-1tofileacomplaintagainstQualcomm.98 TheFTC’scomplaintjoinspendingorconcludedinvestigationsinseveraljurisdictionsaroundtheworld—includingChina,99SouthKorea,100Taiwan,101 Japan,102andtheEuropeanUnion(EU)103—thathavechallengedarangeofQualcommbusinesspractices.TheFTC’s
complaintallegesthatQualcommhasmarketpowerintheworldwidemarketsforCDMAandpremiumLTEchipsetsformobilebasebandcommunications.104 AccordingtotheFTC,Qualcommallegedlyleveragedthismarketpowertosupporta“nolicense,nochips”policywherebydeviceOEMsarerequiredtolicenseQualcomm’sstandard-essentialpatentsatroyaltyratesandlicensetermstheywouldnototherwiseacceptbeforetheyareallowedtopurchasechips.105TheFTCfurtherallegedthatQualcommrefusedtolicenseitsstandard-essentialpatentstocompetingchipsetmanufacturers.AccordingtotheFTC’scomplaint,thesepoliciesallowedQualcommtoimposeananticompetitive“tax”thatmaderivals’chipsetsrelativelymoreexpensiveforOEMs.106Finally,theFTCcontendsthatQualcommcoercedAppleintoenteringanexclusiveagreementformobilebroadbandchipsetsbyofferingpartialrelieffromtheroyaltiesthatQualcommchargedtoApple’scontractmanufacturers(andweresubsequentlypassedthroughtoApple).107 TheFTCallegedthatforeclosingsales
CivilAgencyInvestigations
WSGR 2017 Antitrust Year in Review
9
toApple,aprominentandhigh-volumepurchaser,hadaparticularlysignificantimpactonthemarketbydenyingopportunitiesforrivalstoachieveefficientscaleandtheexperienceandreputationnecessarytomakefurthersales.108
TheFTCCommissionerssplit2-1invotingtoissuethecomplaint.Inararemove,dissentingCommissionerMaureenOhlhausenissuedastatementexpresslycriticizingthetheoryoftheFTC’scomplaint.109CommissionerOhlhausenstatedthatshefeltcompelledtowritebecauseoftheextraordinarypotentialforthecomplainttoundermineU.S.intellectualpropertyrightsabroad,aswellasbecauseofitsunusualtiming—filedthreedaysbeforetheendoftheObamaAdministration.110 Commissioner OhlhausentookissuewiththefactthattheFTC’scomplaintfailedtoallegethatQualcommchargedsupra-competitive,ratherthanmerelyfair,reasonable,andnon-discriminatory(FRAND)royalties.111 Sheobservedthattherewasnorobusteconomicevidenceofexclusionandanticompetitiveeffects,eitherastothecomplaint’s“taxation”theoryoritsallegationsofexclusivedealing,butinsteadthecomplaintwasbasedonwhatamountedto“simplyapossibilitytheorem.”Finally,CommissionerOhlhausennotedthattheFTC’scomplaintnotablyincludedastandaloneclaimunderSection5oftheFTCAct.112UndertheFTC’s2015GuidanceontheenforcementofSection5,suchclaimswouldordinarilybeevaluatedusingtheframeworkoftheShermanAct,makingthestandaloneSection5claimssurprising.113
QualcommmovedtodismisstheFTC’scomplaint,whichthecourtdeniedinJune2017.114
DOJ Anti-Steering Cases Move Toward Resolution
TwoDOJcivilactionsfocusedontheunilateralimpositionofanti-steeringrulesmovedclosertofinalresolutionin2017.
United States v. American Express
InSeptember2016,theSecondCircuitoverturnedtheU.S.DistrictCourtfortheEasternDistrictofNewYork’sfindingthatAmericanExpress(Amex)hadviolatedtheShermanActbyprohibitingmerchantsthatacceptedAmexcardsfromencouragingconsumerstouseotherpaymentcards,whichoftenhadlowermerchantfees.115 ThedistrictcourthadagreedwiththeallegationsoftheDOJandseveralstatesthatthenondiscriminatoryprovisionsAmexenteredintowithretailersrestrainedcompetitionbypreventingmerchantsfromencouragingcustomerstousealternativeformsofpayment(forexample,byofferingdiscountstocustomersusingothercardsorcash),imposingnon-uniformrestrictionsontheuseofAmexcards,orotherwisecriticizingAmex’sservices.116
TheSecondCircuitheldthatthedistrictcourthadappliedanincorrectmarketdefinitionwhichfailedtoconsiderthefeedbackeffectsinamultisidedplatform,anderroneouslyfoundAmextohavemarketpowerbyfailingtoaccountfortherelationshipbetweencardholderdemandforservicesandmerchantattrition.ByfailingtoaccountforthepotentiallybeneficialeffectthattheAmexmerchantrestrictionscreatedforAmexcardholdersandfocusingsolelyonthemerchantsideoftheplatform,theSecondCircuitfoundthatthedistrictcourthadincorrectlydeterminedthatAmex’snondiscriminatoryprovisionsadverselyaffectedcompetition.117
ElevenstatesappealedtheSecondCircuit’sdecision,eventhoughtheDOJdeclinedtoseekcertiorariwiththeco-plaintiffstates.InOctober2017,theU.S.SupremeCourtgrantedcertiorariandargumentwillbeheardin2018.
Carolinas HealthCare
AfewmonthsbeforetheSecondCircuitissued its decision in American Express, theDOJandtheNorthCarolinaattorneygeneralfiledsuitagainstCarolinasHealthCareSystem(CHS),allegingthatitleverageditsmarketpowertorequireeverymajorinsurertoagreenottointroduceplansthatencouragedpatientstouselower-costhospitals.118Accordingtothecomplaint,CHS,whichcontrolsroughly50percentoftherelevantmarket,exertedthismarketpowerbythreateningtocutofftheircontractswithinsurersthatsteerpatientstolower-costproviders.119
OnMarch30,2017,thecourtdeniedCHS’srequestforjudgmentonthepleadings,preservingthegovernment’slawsuitonthegroundsthattheDOJhadplausiblyallegedthatsteeringrestrictionsdriveupinsurancepricesandreducepatients’optionsforcare.120ThecaseremainspendingintheWesternDistrictofNorthCarolina.
FTC and DOJ Continue to Pursue Restraints on Trade in Healthcare and Health Products
In2017,theU.S.antitrustagenciescontinuedtofocusparticularattentiononanticompetitiveagreementsinhealthcareandhealthproducts:
1-800 Contacts
OnOctober30,2017,anadministrativelawjudge(ALJ)upheldtheFTC’scomplaint
WSGR 2017 Antitrust Year in Review
10
allegingthat1-800Contactsenteredintoaseriesofanticompetitivehorizontalagreements,whichtheFTCallegedprohibitedcompetitorsfrompresentingpaidadvertisementsonsearchengineresultsthatwereresponsivetosearchesforitsowntrademarkbrands.121
TheFTChadinitiallyfiledsuitagainst1-800ContactsinAugust2016,claimingthattheonlinecontactlensmanufacturerunlawfullyorchestratedanetworkofanticompetitiveagreementswithatleast14competingonlinecontactlensretailerstoeliminatecompetitioninauctionstoplaceadvertisementsononlinesearchengineslikeGoogleandBing.Accordingtothecomplaint,1-800Contactscoercedcompetitorstoenterintoagreementsnottobidoneachother’sbrandnamekeywordsthroughthreatsoflitigation.1221-800 ContactscontinuestheFTC’sandtheDOJ’slongstandingpracticeoftargetingagreementsnottoadvertise,butintroducesanewcompetitivecontext–searchengineadvertising.123
1-800Contactsargued,unsuccessfully,thatthechallengedagreementswerereasonableeffortstoprotectitsintellectualproperty.124TheALJdisagreedandissuedanorderbarring1-800Contactsfromenteringintobiddingagreementsthatrestrictcompetitioninonlinesearchengineauctionsbyprohibitingrivalsfrompayingtoappearwhenausersearchesfor“1-800Contacts”orothercloselyrelatedterms.125 Moreover,theALJ’sorderforbids1-800Contactsfromenteringintoanagreementwithanothercontactlenssellertorestrict,prohibit,regulate,orotherwiselimitthatseller’suseof“truthful,non-deceptive,andnon-trademark-infringingadvertisingorpromotion.”126
InNovember2017,theFTCgrantedajointmotiontoextendthedeadlinesforfilingappeals,answersandrepliesrelatedtothematter.127
OFTACOOP
OnJanuary19,2017,theFTCissuedafinalorderandenteredintoaconsentagreementsanctioningtheCooperativadeMédicosOftalmólogosdePuertoRico(OFTACOOP),aPuertoRicanophthalmologistcooperativeofroughly100members,fororganizinganexclusionarygroupboycottagainsthealthplan,MCSAdvantage(MCS)andnetworkadministrator,EyeManagementofPuertoRico(EyeManagement).128
AccordingtotheFTC’scomplaint,MCSapproachedEyeManagementtoestablishanewreduced-costnetworkofindividualophthalmologists.UponlearningofMCS’sandEyeManagement’sefforts,OFTACOOPcoordinatedaplanamongitsmemberstoboycottthenewnetwork.TheboycottultimatelyforcedMCSandEyeManagementtoabandontheirplansforareducedcostnetwork.129
ThefinalconsentdecreebarsOFTACOOP from entering into or facilitatingagreementsbetweenoramongophthalmologiststorefusetodealwithanypayorregardingpriceoranyotherterm.ThedecreealsobarsOFTACOOPfromfacilitatinginformationexchange,whichmightassistaboycott,orsuggesting,advising,pressuring,inducing,ortryingtoinduceanyonetoengageinanysimilarconduct.130
Pay for Delay/Sham Petitions
TheFTCcontinuedtoprioritizeillegalpay-for-delaypharmaceuticalsettlementsin2017,extendingapatternthathaslastedsincetheFTC’slandmarkActavis victoryin2013.OnJanuary23,2017, theFTCissuedtwoseparatecomplaintsagainstEndoandImpaxallegingthatEndoenteredintopayfordelaysettlementswithImpaxandotherconspiratorstoprevententryofgenericversionsofLidodermandOpanaERwithImpax.131 OnFebruary7,
2017,theFTCfiledacomplaintinfederaldistrictcourtallegingthatShireengagedinshampetitioningoftheFDAasawaytoobstructgenericentry.132
TheFTChasstatedthatpay-for-delayresultsin$3.5billioninhigherdrugcostseveryyear.TheFTCalsosupportslegislationtoendsuchpay-for-delaysettlements.133
Continued DOJ/FTC Focus on Information-Sharing Agreements
ThefocusonanticompetitivecollusionbytheDOJandtheFTChasnotbeenrestrictedtothedrugandmedicaldevicecontext.Theagenciesalsofocusedoninformation-sharingagreements,whichtheagenciesviewashavingastronglikelihoodofrestrictingcompetitionandenablinganticompetitivebehavior.
Guidelines for HR Professionals: Information-Sharing in Labor Markets
Inlate2016,theDOJandtheFTCjointlypublishedapapertitled“AntitrustGuidanceforHumanResourcesProfessionals”(HRGuidance).134AswedescribeinfurtherdetailintheCriminalEnforcementsectionofthisreport,theHRGuidancehighlightedthatcertainformsofhorizontalcollusionandinformationexchangeswithinthelaborandemploymentcontextcouldviolatetheantitrustlaws.Informationaboutwages,employeesalary,orothertermsofcompensation,eitherataspecificlevelorwithinarangeisofparticularconcernbytheagencies.TwoDeputyAssistantAttorneysGenerals(AndrewFinchandBarryNigro)havecommentedpubliclythattheDOJisreadyingcasesagainstsuchagreements.Companiesthathaveengagedinbenchmarkingstudiesandanalysisorhavetradeassociationparticipationonhumanresourcesissueswillwanttopaycloseattentiontothe
WSGR 2017 Antitrust Year in Review
11
DOJ’spursuitinthisspace,particularlygiventhebroadimplicationsforhiringandthesettingofwagesandcompensationinvariouscontexts.
DIRECTV
InMarch2017,theDOJsettleditsongoingcaseagainstDIRECTVandAT&T.TheDOJhadoriginallysuedDIRECTV(anditscorporatesuccessor,AT&T)inNovember2016,forallegedcollusionandunlawfulinformation-sharingwithcompetitorsduringnegotiationstocarryDodgersbaseballgamesintheLosAngelesarea.ThecomplaintallegedthatDIRECTVcolludedwithcompetitorsCoxCommunicationsandCharterCommunicationstoavoidcompetingforaccesstoDodgersbroadcastrights.135 DIRECTVallegedlykeptitscompetitorsupdatedonthestatusofnegotiations,andmadeassurancesthatitwasnotplanningtobidontherightsatthepricethatTimeWarnerwasdemanding.136
AccordingtotheDOJ,thesettlement“willobtainallofthereliefsoughtbythedepartmentinitslawsuit,”includingrequiringthecompaniestomonitorcertaincommunicationstheirprogrammingexecutiveshavewiththeirrivals,andtoimplementantitrusttrainingandcomplianceprograms.137
TheDOJemphasizedtheparticularimportanceofaggressiveenforcementinmarketslikecabletelevisionbroadcastrights,wherecustomersmayonlyhave“ahandfulofchoicesinthemarketplace.”138
American Guild of Organists
InMay2017,theFTCissuedafinalorderandenteredintoaconsentagreementwiththeAmericanGuildofOrganists(AGO),anationaltradeassociationfororganistsandchoralconductors.139Undertheconsent
agreement,AGOagreedtoeliminaterulesthattheFTCfoundtorestrictitsmembersfromcompetingforopportunitiestoperforminviolationofSection5oftheFTCAct.140
Specifically,theFTCallegedthatAGOrestrainedtradebypromulgatingaCodeofEthicsandmodelcontractsthatlimitedthefreedomoforganistsandchoraldirectorstoseekoracceptengagements.Memberswererequiredtoseektheconsentofanincumbentmusicianatavenuebeforeacceptingtheengagement,forcingconsumerstopayforboththechosenmusicianandtheincumbentmusician(eventhoughonlythechosenmusicianperformsattheevent).141Inaddition,AGOallegedlydevelopedandenforcedascheduletobeusedbyAGOchapterstosetregionallyapplicablecompensationschedules,basedonwhichAGOmemberssettheirfees.142
ThefinalconsentagreementrequiredAGOtostoprestrainingitsmembersfromsolicitingworkorissuingcompensationschedules,guidance,ormodelcontractsbasedonwhichmembersdeterminetheirfees.143Inaddition,AGOisalsorequiredtoimplementanantitrustcomplianceprogramandtostoprecognizingchaptersthatfailtocertifycompliancewiththeorder’sprovisions.
Louisiana Real Estate Appraisers Board
InMay2017,theFTCfiledanadministrativecomplaintchargingtheLouisianaRealEstateAppraisersBoard(LREAB)withrestrainingpricecompetitionamongappraisalmanagementcompaniesbeyondthedictatesoftheDodd-FrankAct,whichrequiresappraiserstocharge“customaryandreasonablerates.”144 Then-ActingDirectoroftheBureauofCompetitionTadLipskynotedthe
significanceofthiscomplaintasthefirstFTCcomplaintagainstastateboardsincetheU.S.SupremeCourt’sdecisionintheNorth Carolina State Board of Dental Examiners case.145
Thechallengedconductwastheboard’spolicythatappraiserssettheirfeesexclusivelybasedonthemethodsprescribedbytheboard.146Further,theboardallegedlycommissionedannualreportsofthemedianfeeschargedindifferentregionsinLouisiana,postedthereportsonitswebsite,andrequiredappraiserstochargefeesthatareequaltoorexceedsuchmedianfees.147Theboardallegedlytookenforcementactionsagainsttheappraiserschargingfeesbelowthepublishedmedianfees,resultinginagreementsbytheseappraiserstoraisethefeessothattheyequalorexceedthemedianfees,aswellaswidepresscoverageoftheboardenforcementactionsandtheiroutcomes.148
TheFTCallegedthattheboard’sconductconstitutedconcertedactionthatunreasonablyrestrainstradeunderSection5oftheFTCAct.149Withrespecttothestateactiondoctrine,theFTCarguedthatneithertheDodd-FrankActnorthestatelawimplementingitrequiredtheboardtosetcustomaryandreasonablefeesatanyparticularlevel.150Further,theFTCarguedthatstatelawdidnotclearlyarticulateanintentiontodisplacecompetitioninthesettingofappraisalfees,andthatstatesmaycomplywithDodd-Frankrequirementswithoutviolatingtheantitrustlaws.151 A motion to dismiss is nowpendingbeforetheadministrativelawjudge.152
National Association of Animal Breeders
InSeptember2017,theFTCissuedafinalorderandenteredintoaconsent
WSGR 2017 Antitrust Year in Review
12
agreementwiththeNationalAssociationofAnimalBreeders(NAAB)wherebyNAABagreedtorefrainfromadoptingrulesthatstiflecompetitionamongstitsmembersinthebuyingorsellingofdairybullsorbullsemenforartificialinsemination.153
TheNAAB,incooperationwiththeU.S.DepartmentofAgriculture,developedagenomictestingtechnologythatbetterpredictstheabilityofthebulltotransmitcommerciallyimportanttraits,whichissuperiortothetraditionalmethodforpredictingsuchability.154TheFTC’scomplaintchallengedaNAABrulerequiringmemberstoalreadyhaveafinancialinterestinabullinordertousethetechnologyonthebull.TheFTCallegedthatthisresolutionprohibitedmembersfromsellingthetechnologytonon-membersforthenon-members’bullswithouthavinganinterestinthenon-members’bulls,andtherefore“impededthedevelopment”ofthismarket.155TheFTCallegedthataccesstothetechnologywould“tendtodrivethepriceofthebulltowarditstruevalue,”sotheresolutioninjurednon-membersbyrestrainingcompetitionamongNAAB’smembers.156
EuropeGoogle Shopping and AdSense
OnJune27,2017,theECannouncedtheconclusionofitsseven-yearinvestigationintoGoogle’ssearchservice,findingthatGooglehadleveragedadominantmarketpositioningeneralsearchtoadvantageitsowncomparisonshoppingservice(CSS)inviolationofArticle102TFEU.157 TheEC’sobjectionscenteredonthepositionanddisplayofproductsearchresultsandadvertisementsonGoogle’ssearchresultspage.TheECfoundthatGooglegaveprominentplacementtotheProductUniversalandGoogleShoppingAdsonitssearchresultspages.TheECalsofoundthatGoogleapplieddifferentrankinganddisplayalgorithmstotheProductUniversalandShoppingAdsthan
toCSSsitesappearinginGoogle’sorganicsearchresults,whichtheECfoundweresystematicallydemotedbasedonfactorsinherenttoGoogle’sorganicwebsearchalgorithms.158
TheECfoundthatGooglehasbeendominantsince2008in“generalinternetsearch”throughouttheEEAandthatGooglesearchresultsareanimportantsourceoftrafficforrivalCSS.AccordingtotheEC,Google’sconductcausedtrafficfromGooglesearchresultspagestorivalCSStodecline,impairingtheirabilitytocompeteagainstGoogle’sownCSS.TheECfinedGoogle€2.42billion(approximately$3.24billion)—thelargestpenaltyeverimposedbytheEC—andrequiredGoogletomodifyitssearchenginesoasto“applythesameprocessesandmethodstopositionanddisplayrivalcomparisonshoppingservicesinGoogle’ssearchresultspagesasitgivestoitsowncomparisonshoppingservice.”159
Inablogpostfollowingthedecision,GooglearguedthattheECundervalueduserpreferenceforadirectlinktoamerchantsite,likethatprovidedbyitsShoppingAds,ascomparedtoaCSSwheretheusermustrepeattheirsearch.160Googlealsohighlightedintensecompetitionfromglobale-commercegiants,suchasAmazonandeBay,asanalternativeexplanationforsomeCSS’declineinpopularity.161InlateAugust2017,GooglesubmittedaremedyproposalwherebyeachslotintheCommercialUnitwouldbefilledthroughasingleauctionthatrankedproductoffersfromGoogleShoppingandrivalCSSusingthesamecriteria.162GooglefiledanappealoftheEC’sdecisionwiththeEUGeneralCourtthefollowingmonth.163
Intel – Decision of the ECJ
Inamuch-anticipatedjudgmentdeliveredonSeptember6,2017,theEU’shighestcourt,theECJ,setasideaGeneralCourt(GC)rulingthatupheldanEC
decisionimposingfinesof€1.06billion(approximately$1.3billion)onIntel.164
In2009,theEuropeanregulatorfoundthatIntelhadabuseditsdominantpositionbygrantingloyaltyrebatestoPCmanufacturersconditionalupontheirsourcingall,oralmostall,oftheirx86CPUsfromIntelandthusforeclosingacompetitor,AMD,fromthemarket.165TheGC,upholdingthedecisiononappealbyIntel,haddeclaredthatloyalty-inducingexclusivityrebatesgrantedbyadominantundertakingareperseillegal.166
Inoverturningthelowercourt’sruling,theECJembracedaruleofreasonandheldthatitisnotnecessarilyillegalforadominantcompanytograntrebatesconditionalonexclusivity.Adominantcompanymaysubmitevidencetorebutapresumptionofabuseandshowthatitsconductisnotrestrictiveofcompetition.Whereitdoesso,theECisrequiredtoassessthecompany’scapacitytoforeclosecompetitorsthatareatleastasefficientasthedominantfirm.TheECmustalsoassesswhetheranyforeclosureeffectiscapableofobjectivejustificationandmaybeoutweighedbyefficienciesthatbenefitconsumers.
TheECJobservedthatthe“asefficientcompetitor”(AEC)testhadplayedanimportantroleintheEC’sassessmentofIntel’sabilitytoforeclose.ThelowercourtwasthusrequiredtoconsiderallofIntel’sargumentsrebuttingtheEC’sconclusionsonthetest,buthadfailedtodoso.Inlightofthisfailure,theECJheldthatthejudgmentshouldbesetasideandthecaseremandedbacktothelowercourtforrehearingonthispoint.
Itcouldbeseveralyearsbeforeafinaldecisionisreachedinthealready18-yearoldsaga,especiallyifeitherIntelortheECappealafutureGCjudgment.However,thecaseindicatesthattheECwillneedtocarefullyconsidereconomiccontextinfutureabuseofdominanceinvestigations.
WSGR 2017 Antitrust Year in Review
13
Excessive Pricing
EU Aspen Pharma Investigation
TheEChastraditionallybeenreluctanttolaunchexcessivepricingcases,inpartduetothedifficultiesinvolvedinpointingtowhatisagenuinelyexcessiveprice.However,onMay15,2017,theECopenedaninvestigationintoAspenPharmacare’spricingoffivecancerdrugsinthefirstECcompetitioninvestigationintoexcessivepricingpracticesinthepharmaceuticalsector.TheEChasconcernsthatAspenmayhaveabuseditsdominantpositionbyimposingsignificantpriceincreasesofuptoseveralhundredpercent(so-called“price-gouging”)inbreachofArticle102TFEU.TheECwillalsoinvestigateallegationsthatAspen,inordertoimposethepriceincreases,threatenedto(ordid)withdrawthedrugsinsomeEUmemberstates.167
TheEC’sinvestigationcoversalloftheEEAexceptItaly,whereAspen’sconducthasalreadybeenthesubjectofafine.IftheECfindsthatAspenhasimposedexcessiveprices,itcouldfaceafineofupto10percentofitsglobalturnover.Aspencouldalsobesubjecttoprivatedamagesactionsbeforenationalcourts.
Whilecompetitionauthoritiesgenerallydonotwishtobeseenaspriceregulators,theEC’sinvestigation,andthenationalcasesbelow,makeclearthatwhereapharmaceuticalcompanyissuspectedofexploitingthenon-brandedstatusofadrug(meaningitisnolongersubjecttopriceregulation)inordertoincreaseprices,thiscouldconstituteaviolationofEUlaw.PharmaceuticalcompaniesshouldthereforebeextremelyvigilantwithregardtotheirpricingschemesintheEU,particularlywhereoff-patentdrugsareinvolved.
UK Pharmaceutical Cases
InOctober2017,theUK’sCompetitionandMarketsAuthority(CMA)confirmed
thatitwasinvestigatingAspenPharmacareoverallegedanticompetitiveconductinthesupplyofbloodpressureandarthritisdrugs.168TheCMAisalsoinvestigatingActavisUKandConcordia.ActavisisunderCMAscrutinyforallegedlychargedexcessivepricesforhydrocortisonetablets—imposinganincreaseofover12,000percentcomparedtothepreviousbrandedversionsoldbyanothercompany.169Concordia,whichfocusesonoff-patentdrugs,isunderinvestigationforallegedexcessivepricinginthesupplyofdrugsforhypothyroidism,includingtotheUK’snationalhealthservice(NHS).170
ThesecasesbuildontherecordfinesimposedbytheCMAonPfizerandFlynnPharmainDecember2016.PfizerhadsoldtherightstodistributethedrugtoFlynn,whichsubsequentlymadethedruganunbrandedgeneric,meaningthatitwasnolongersubjecttopricecontrols.Thecompanieswerefinedalmost£90million(approximately$120.5million)forchargingexcessiveandunfairpricestotheNHSforanepilepsytreatmentdrug,implementingincreasesofupto2,600percent.171
“Distribution” Cases
Amazon e-Books – MFN Clauses
InMay2017,theECadoptedadecisionformallyacceptingcommitmentsofferedbyAmazoninrelationtotheregulator’se-booksinvestigation.172 TheEC’sinvestigationwaslaunchedinJune2015andfocusedonso-calledmost-favored-nation(MFN)clausesinAmazon’sdistributionagreementswithe-bookpublishersinEurope.TheECwasconcernedthatAmazonwasusingitsdominantpositioninthemarketsfortheretaildistributionofEnglishandGermanlanguagee-bookstomakeitmoredifficultforothere-bookplatformstoinnovateandcompeteeffectivelywithAmazon.
TheseMFNclausesrequiredpublisherstooffersimilar(orbetter)termstoAmazoncomparedtoitsrivalsandtoinform
AmazonaboutmorefavorableoralternativetermsgiventoAmazon’scompetitors.TheclausescoverednotonlypricebutmanyaspectsthatacompetitormightusetodifferentiateitselffromAmazon,suchasdifferentdistributionmethodsorreleasedates,featuresofe-books,orapromotion.
InresponsetotheEC’sconcerns,Amazonofferedtoremovetheoffendingclausesfromitscontractsandrefrainingfromusingsuchclausesforaperiodoffiveyearswithregardtoanye-bookinanylanguagedistributedbyAmazonintheEEA.
Coty – Selective Distribution
OnDecember6,2017,theECJruledthatasupplierofluxurygoodscanprohibititsauthorizeddistributorsfromsellingonlineviathird-partyplatforms.173ThecaseconcernsadisputebetweenU.S.-basedperfumeandcosmeticssupplier,CotyInc.,andoneofitsGermandistributors,ParfümerieAkzente(PA),whichrefusedtocomplywithaclauseinCoty’scontractspreventingitsretailersfromsupplyingCotyproductsviaonlinethird-partyplatforms,suchasAmazonandeBay.AGermancourtsoughtguidancefromtheECJastowhethertheclausewaslegalandenforceableunderEUcompetitionlaw.
TheEU’shighestcourtruledthataselectivedistributionnetwork,designedprimarilytopreservetheluxuryimageofcertaingoods,canbevalidprovidedtwoconditionsaremet:(1)theresellersareselectedonthebasisofnon-discriminatoryandobjectivequalitativecriteria;and(2)thecriteriausedareproportionate.Asforrestrictionsononlinesalesviathird-partyplatforms,theECJfoundthatthesewillnotbedeemedanticompetitivewheretherestrictionisproportionateanddesignedtopreservethegoods’luxuryimage,anditisappliedinanon-discriminatorymanner.
Thecourt’srulingappearslimitedtoprestigeproductswhichcarryanauraofluxury.Companieswithover30percent
WSGR 2017 Antitrust Year in Review
14
marketshare—i.e.,thosethatareineligibleforsafeharborprotection—willneedtoconsiderwhethertheirproductsmeritsimilarprotectionasprestigegoods.Otherwisetheirselectivedistributionnetworksandrestrictiveclausesriskbeingstruckdown.
Luxury Brand Watch Makers
OnOctober23,2017,theGCaffirmedtheEC’sdecisiontocloseaninvestigationintocertainluxurybrandwatchmakers(includingLVMHMoëtHennessy-LouisVuitton,Rolex,andtheSwatchGroup).174 Theappellant,CEAHR,allegedthattheluxurybrandwatchmakershadabusedtheirdominantpositionsbyimplementingselectivedistributionsystemsforrepairservicesandrefusingtosupplysparepartstowatchrepairersthatwerenotpartoftheirauthorizedrepairandmaintenancenetwork.TheGCnotedthatforarefusaltosupplytoconstituteanabuse,itmust:(1)notbeobjectivelyjustified;(2)berelatedtogoodsandservicesthatareindispensablefortherequestingperson’sactivity;and(3)belikelytoeliminateallcompetition.TheGCupheldtheEC’sfindingthattherewasalowprobabilityofalleffectivecompetitionbeingeliminated.
WhiletheGCdidnotgoasfarastheECJwouldinCotyinstatingthatthepreservationofaluxurybrandimagealonecouldbeajustificationforarestrictionofcompetition,itdidholdthattheobjectivesofpreservingthequalityofproducts,ensuringtheirproperuse,andpreventingcounterfeitingmayjustifysucharestriction.Forcompanieswishingtosupplysparepartsforluxurygoodssolelytoauthorizedpartners,thisjudgmentprovidesaclearframeworkwithinwhichtoimplementapermittedselectivedistributionnetwork.
Lithuanian Railway Operator Case
OnOctober2,2017,theECfinedLithuanianRailwaysalmost€28million(approximately$37.5million)forabusingitsdominantpositionontherailfreightmarketbyremovingpublicrailinfrastructureconnectingLithuaniaandLatvia.175
ComplainantABOrlenLietuva(Orlen)usedLithuanianRailway’srailfreightservicestotransportrefinedcrudeoilproductsfromitsrefineryinLithuaniatoportsinLatvia.AfterOrlenconsideredcontractingwithadifferentrailoperatorin2008,LithuanianRailwaysuseditscontroloverthenationalrailinfrastructuretodismantlea19kmlongsectionofrailtrackconnectingLithuaniaandLatvia,closetoOrlen’srefinery.ThiseffectivelypreventedOrlenfromusinganalternativefreightsupplier,asitwouldneedtotakeamuchlongerroutetoreachLatvia.
FollowingacomplaintbyOrlen,theECopenedformalantitrustproceedingsagainstLithuanianRailwaysinMarch2013.TheECfoundthatLithuanianRailwaysfailedtoevidenceanyobjectivejustificationfortheremovalofthetrack,suggestingthatthedismantlingof19kilometersofrailwaywassolelytopreventamajorcommercialcustomerfromusingtheservicesofacompetitor.
EU Double Jeopardy
InajudgmentissuedonNovember23,2017,theECJruledthatconductthathasledtotheECacceptingcommitmentscanstillgiverisetoparallelnationalproceedings.176
In2006,theECacceptedcommitmentsfromRepsol,anoilandgascompany,inlieuofaformalfindingofinfringement,
bringingitsinvestigationintolong-termexclusivesupplyagreementstoaclose.InsubsequentnationalproceedingsinSpain,Gasorba,oneofRepsol’sservicestationtenants,challengeditssupplyagreementwithRepsol,claimingthatitinfringedArticle101TFEU,whichprohibitsanticompetitiveagreements.TheSpanishSupremeCourtreferredtheissuetotheEU’shighestcourt,requestingguidanceonwhetheranationalcourtisprecludedfromfindinganagreementinfringesArticle101TFEUwheretheEChasalreadyacceptedbindingcommitmentscoveringthatsameagreement.
TheECJruledthatanECcommitmentdecisiondoesnotaffectthepowerofnationalcourtstoapplyEUcompetitionlawtoconductthattheEChasalreadyinvestigated.WhilenationalcourtsareobligednottotakedecisionsthatarecontrarytothoseadoptedbytheEC,thenatureofcommitmentdecisionsissuchthattheydonotestablishwhethertherehasbeenanantitrustviolation.However,thejudgmentclarifiedthatnationalcourtsareexpectedtotreatcommitmentdecisionsasan“indication,”ifnotprimafacieevidence,oftheanticompetitivenatureofanagreement.
CompaniesshouldbemindfulthatchoosingtonegotiatecommitmentswiththeECsoastoavoidapotentialfiningdecisiondoesnotmeanthechapterisnecessarilyclosedontheirEUliability,andtheyarestillopentoprivateenforcementanddamagesclaimsbeforenationalcourts.ThesetwofactorshighlighttheneedforamorenuancedinternalstrategizinginthefutureforcompaniesaccusedofanticompetitiveconductastowhethertonegotiatecommitmentswiththeECorchallengetheallegations.
WSGR 2017 Antitrust Year in Review
15
CriminalantitrustenforcementremainedacorefocusoftheU.S.DepartmentofJustice(DOJ)in2017.Whilecriminalantitrustfinesforcorporationsweresignificantlylowerthispastyear,theDOJ’scommitmenttovigorouscriminalantitrustenforcementhashistoricallyremainedunchangedinbothRepublicanandDemocraticadministrations.TheDOJdemonstratedthisbyinitiatingseveralsignificantinvestigations,prosecutinganumberofdomesticandinternationalcartelmatters,holdingmoreindividualsaccountable,andadvancingcertainpolicyinitiatives.ThissectionofourAntitrustYearinReview:(i)identifiesafewnotabledevelopmentsintheDOJ’scriminalenforcementprogramin2017;(ii)summarizestheDOJ’ssignificantcriminalprosecutionsofcorporationsandindividualsinthelastyear;(iii)describesrecentpolicyinitiativesandprioritiesintheDOJ’scriminalenforcementprogram;and(iv)highlightssomesignificantdevelopmentsincartelenforcementoutsidetheU.S.
NotableDevelopmentsintheDOJ’sCriminalAntitrust Enforcement ProgramFirst,aswithotherareasofantitrustenforcement,2017wasayearoftransitionfortheDOJ’scriminalenforcementprogramandleadership.UponthedepartureofthepriorActingAssistantAttorneyGeneralRenataHesse,headofCriminalEnforcementBrentSnyderservedasActingAssistantAttorneyGeneral.Uponhisrecentdeparture,MarvinPrice,whopreviouslyservedastheDirectorofCriminalEnforcement,tookoverasthe
headofthecriminalenforcementprogram.MichelleRindone,aformerAssistantChiefintheNewYorkoffice,isservingasActingDirector.TheDOJiscurrentlysearchingtoappointapermanentDeputyAssistantAttorneyGeneralforCriminalEnforcement,andweexpectthissearchwillconcludeinthenearfuture,somorechangesaresoonto come.
Second,thisyearwillendwithloweroverallcorporatefinesforcriminalantitrustviolationsascomparedwithprioryears.InFY2017,theDOJnetted$107.8millionincorporatecriminalfines.Thismarkedasignificantdecreasecomparedtopreviousyears;indeed,itisa73percentdecreasecomparedtoFY2016,a97percentdecreasecomparedtoFY2015,anda91percentdecreasecomparedtoFY2014.Therecouldbeanumberofreasonsforthisdrop,includingthatintheimmediateprioryears,theDOJconcludedsomesignificantprosecutions,whilethenextwaveofinvestigationscommencedin2017,andwilltakesometimefortheDOJtoseetheresultsofthoseinvestigations.Indeed,inFY2016,theDOJinitiated23criminalgrandjuryinvestigations—thehighestnumbersinceFY2009.AnumberofthesenewDOJprobesandgrandjuryinvestigationswerereportedinthepressin2017,includinginvestigationsintoadvertising,Chineseaircargoservices,andmetalpaintsandcoatings.Thesearenewinvestigationstowatchin2018.
Third,insetbacksfortheDOJ,twocorporatedefendantswereacquittedofcriminalchargesaftertrialsin2017.Bothcorporatecasesinvolveddefenseargumentsregarding“ruleofreason”-typeevidencethatisnottypicallyadmissibleinacriminalcaseallegingaperseviolation.Althoughtherearecase-specificreasons
fortheseacquittals,anoverallpointisthatbusinessrationalesthatarenotoftencreditedbytheDOJinthecourseofpleanegotiationsmayresonatewithU.S.judgesandjuries.ThefirstcasewasUnited States v. Kemp & Associates, involvingthesupplyofheir-locationservices.Inthatcase,theDOJallegedthatthedefendantsconspiredwithoneanothertoallocateheirsentitledtoaninheritancefromarelativethatdiedintestate.TheDOJfurtherallegedthatthedefendantswouldsplitthehigherfeestheywereabletochargebyavoidingdirectlycompeting.Thedefendantsfiledamotiontodismiss,arguingthatthecaseshouldnotbesubjecttothepersestandard(andthusnotprosecutedasacriminalcase),butinsteadanalyzedundertheruleofreasonstandard(andthusprosecuted,ifatall,asacivilcase).Thecourtagreedwiththedefendants,observingthatthearrangementwassufficiently“unusual”andmayhavecreatedthepotentialforincreasedefficiencyinestateadministration,sotheperserulemightnotbeappropriate.Thecourtheldthatinanyevent,theactionwastime-barredunderthestatuteoflimitationsandshouldbedismissed.TheDOJhasappealedthatrulingtotheTenthCircuit.
Thesecondcase,United States v. Tokai Kogyo Co. Ltd., et al.,involvedthesupplyofautomotivebodysealingparts(i.e.,weatherproofing)tocertainautomobileOEMs.TheDOJallegedthatTokaiconspiredwithothersupplierstofixpricesandrigbidsonthoseproducts.Inthatcase,theDOJchargessurvivedamotiontodismiss,andthecasewastriedbyajury.AmongthedefenseargumentswasthatHonda,thecustomertowhomautopartsweresold,hadaprocurementprocessthatitselfallocatedsalesand
CriminalCartelInvestigations
WSGR 2017 Antitrust Year in Review
16
facilitatedtheallegedcollusion.Followinga13-daytrial,however,thejuryacquittedthedefendantsafterlessthanfourhoursofdeliberation.
Fourth,ithasbecomeapparentthattheDOJhasbeenproactivelylookingtoidentifycollusiveconduct(andinitiatecriminalinvestigations)throughsourcesandmeansoutsideofitsLeniencyProgram.AlthoughtheDOJhistoricallyhasstatedthatitobtainsleadsfromothersources(e.g.,investigatingagentsandcomplainingparties),manyofthelargestcriminalinvestigationshavebegunwithacorporateleniencyapplicant.Morerecently,however,oneoftheinvestigatorysourceshasbeenitscivilenforcementprogram.Forexample,theDOJprosecutedthreeexecutivesandonecorporatedefendantin2017forallegedcollusioninthesupplyofpackagedseafood.ThisinvestigationstartedwhentheDOJuncoveredevidenceofpotentiallycollusiveconductwhilereviewingaproposedmergeroftwopackagedseafoodcompanies.Asanotherexample,inMarch2017,theDOJsecureda15-monthprisonsentenceforanexecutivechargedwithconcealinginformation,destroyingdocuments(anddirectingsubordinatestoalsodoso),andmakingfalseandmisleadingstatementsduringaDOJcivilinvestigationofajointventurebetweentwoNewYorktourbuscompanies.Inthepast,theDOJhasbeencriticizedforrelyingtooheavilyonitsLeniencyProgramtodetectcriminalconduct,andwhetherthecriticismiswarrantedornot,itdoesappearthattheDOJisnowlookingbeyonditforevidenceofcartelconduct.TheDOJattorneysarewellattunedtoantitrustviolationsofalltypes,andwhenevidenceisuncoveredevenincivilcontexts,theDOJhasnothesitatedtopursuesuchconductcriminally.
NotableProsecutionsin2017:CorporationsandIndividualsIn2017,theDOJcontinuedinvestigatingandprosecutingcollusiveconductacrossvariousindustries.Asnoted,theDOJnettedapproximately$107.8millionincorporatefinesinFY2017,177 whichrepresentsasignificantdecreasefrompreviousyears.TheDOJ,however,chargedmorethan20individualsduringthepasttwelvemonthsandcontinuedtoseeksignificantsentencesagainstindividuals.Manyoftheindividualssentencedin2017receivedjailtermsofbetween14and24monthsandwereorderedtopaysubstantialfines.TheDOJ’saggressiveapproachagainstindividualsshouldnotcomeasasurprise.TheDOJhasissuedmultiplepolicydirectivesoverthelastthreeyearsdetailingitsintenttoincreaseenforcementagainstindividualsinvolvedincriminalantitrustconduct.178 SomeofthemoresignificantDOJprosecutionsfromthisyeararediscussedbelow.
• Automotive Parts. The DOJ’spursuitofantitrustviolationsintheautomotivepartsindustryisinternationalinscopeandhascovereddozensofcomponentsusedtomanufactureautomobiles.Thoughtheinvestigationscontinuedin2017,ascomparedwithpreviousyears,theinvestigationsseemtobewindingdown.Thisyear,theDOJyielded$61.58millionincorporatefinesfromautopartsmanufacturers,downfrom$270milliontheyearbefore.Mostrecently,andasnotedabove,inNovember2017,afederaljuryinOhioacquittedTokaiKogyoanditssubsidiary,GreenTokai,onchargesoffixingpricesonautomotivebodysealingproducts
andriggingbidsonautomotivesteeltubes.Althoughthetriallasted13days,thejurytookonlyfourhourstodeliberateandreturnitsverdict.TheDOJalsocontinuedtochargeindividuals.InFebruary2017,thepresidentofaU.S.jointventureofanautomotivebodysealingproductssupplierpleadedguiltyandagreedtoserve14monthsinprison,inadditiontopayinga$7,500criminalfine.
• Electrolytic Capacitors. Sincetheoutsetoftheinvestigationinthecapacitorsindustryin2014,eightcompaniesandtenindividualshavebeenchargedwithparticipatinginanallegedconspiracy.In2017,theDOJcontinuedtoextractguiltypleasfrommanufacturers,includingMatsuoElectricandNichiconCorporation.Totalfinesimposedfor2017exceeded$62million,179 withNichiconCorporation’s$42millionfinemakingupthebulkofthisnumber.InOctober,theDOJsecureditsfirstindictmentofacompanyintheinvestigation,whenagrandjuryindictedNipponChemi-ConCorporation(NCC).TheDOJisexpectedtogototrialagainstNCCinOctober2018.Notably,JudgeJamesDonatooftheU.S.DistrictCourtfortheNorthernDistrictofCaliforniahasbeencarefullysecuritizingandincreasinglycriticizingthepleaagreementsinthiscase.Inthepastyear,JudgeDonatorejectedthreecapacitorcompanies’pleadeals,includingMatsuoElectric’s,findingthatthecriminalfinesweretoolowanddidnotservethebestinterestofjustice.Further,JudgeDonatohasvoicedhisreservationsaboutTypeCpleaagreementsbecausetheytakeawayacourt’sdiscretioninsentencing.
WSGR 2017 Antitrust Year in Review
17
ThishascausedtwocompaniestoenterintoTypeBpleaagreementswiththeDOJ.ATypeBpleagivesthecourtsignificantlymorediscretioninthesentencethatcanbeimposed.In2017,theDOJalsoturneditsattentiontoindividuals,andinFebruary2017,aMatsuoexecutivebecamethefirsttopleadguiltyinthecapacitorinvestigation,agreeingtoserveaoneyearandonedayprisonsentence.Nineotherexecutiveswerepreviouslyindictedin2016and2015inconnectionwiththeinvestigation.
• Ocean Shipping – Roll-On, Roll-Off.TheDOJhasinitiatedseveralinvestigationsintotheoceanshippingindustry.TheDOJ’s“roll-on,roll-off”cargoinvestigationcontinuedtopickupsteamoverthelastyear,withHöeghAutolinerspleadingguiltyinSeptember2017andagreeingtopaya$21millionfineforallocatingcustomers,riggingbids,andfixingpricesforthesaleofroll-on,roll-offcargoshipments.HöeghAutoliners’pleaagreementbringsthetotalcriminalfinesimposedtoover$255million.Additionally,theDOJannouncedtheindictmentofthreeWalleniusWilhemsenLogisticsexecutivesinJune2017;notably,thisinvestigationhasalreadyresultedinlengthyprisontermsforfourexecutives,whileanadditionalsevenexecutiveshavebeenindictedbutremainfugitives.
• Ocean Shipping – Containers.Alsoinoceanshipping,inMarch2017,theDOJconductedasearchatabiannualmeetingoftheInternationalCouncilofContainershipOperators—knownasthe“BoxClub”—andservedgrandjurysubpoenasonseveralcontainershipoperators,includingMoller-Maersk,
Evergreen,theOrientOverseasContainerLine,andHapagLloyd,aswellasmanyexecutives.Sincemanyofthesubpoenarecipientsarebasedoverseas,theDOJusedtheBoxClubmeetinginSanFranciscoasanopportunitytoservethesubpoenasonforeignentitiesthatmightotherwisebemorechallengingtoreach.Todate,therehavenotbeenanychargesfiledintheinvestigation.
• Packaged Seafood. In its investigationintosuppliersofpackagedseafood,theDOJobtainedaguiltypleafromBumbleBeeFoods,whichagreedtoa$25millionfineforitsroleinaconspiracytofixthepricesofshelf-stabletunafish.BumbleBee’sfinerepresentedareductionfromtheinitialfineofover$136million,becauseofconcernsaboutthecompany’sabilitytopayandremainaviablecompetitor.BumbleBeewasthefirstcorporatedefendanttopleadguiltyintheinvestigation,whichhadalreadyseenseveralguiltypleasfromexecutives.AformerStarkistsalesexecutiveisawaitingsentencingafterpleadingguiltyinJune2017tofixingthepricesofpackagedseafood.Todate,threeindividualshavepleadedguiltytotheirroleintheallegedconspiracy.InSeptember2017,Tri-UnionSeafoods,theU.S.subsidiaryofThaiUnionGroup,disclosedthatitwasthewhistleblowerandhadagreedtocooperatewiththeDOJinexchangeforconditionalleniency.
• E-Commerce: Promotional Products. InAugust2017,theDOJsecuredguiltypleasfrombothCustomWristbandsandZaappaazfortheirrolesinanallegedconspiracytofixpricesforpromotionalproducts,includingcustomizedwristbandssoldonlinetoU.S.customers.
Thecompaniesagreedtopayfinesof$409,342and$1.9million,respectively.TheDOJalsoreportedlyisinvestigatinganOhio-basedpromotionalcompany,Totally-Promotional.Interestingly,theDOJallegedthatthecompaniesprimarilycarriedouttheconspiracyviasocialmediaandmessagingapplications,includingFacebook,WhatsApp,andSkype.InitspressreleaseannouncingZaappaaz’sguiltyplea,theDOJemphasizedthat“criminalscannotevadedetectionbyconspiringonlineandusingencryptedmessaging.”Asforindividuals,in2017theDOJ’sinvestigationnettedtwoguiltypleasfromhigh-levelexecutives.
• Generic Pharmaceuticals. In 2017, theDOJcontinueditslong-runninginvestigationintocollusionamonggenericdrugmanufacturers,buttodate,therehasbeennocorporatechargeorguiltyplea.Aspartofthisinvestigation,theDOJreportedlyconductedadawnraidofgenericpharmaceuticalmakerPerrigoCo.’scorporateofficesinMay2017.Twoformerexecutiveshaveenteredguiltypleasinthecaseforfixingprices,riggingbids,andallocatingcustomersfortwogenericdrugs.Aparallelcivillawsuitconcerningthosetwodrugswasalsobroughtbyattorneysgeneralfrom45statesandtheDistrictofColumbia.InOctober2017,theattorneysgeneralfiledamotionforleavetoamendthecomplainttoincludeanadditional12companiesand13newdrugs.Defendantsopposedthemotioninpart,andadecisionisexpectedinearly2018.
• Real Estate Foreclosure Auctions. TheDOJcontinuedaggressivelytopursueenforcementinthearea
WSGR 2017 Antitrust Year in Review
18
ofrealestateforeclosureauctionservicesin2017,inaninvestigationthathasresultedinasignificantnumberofchargesagainstindividuals.In2017,nineindividualsinCalifornia,Florida,Georgia,andAlabamawerechargedorsentenced,threeofwhomreceivedprisontermsrangingfrom14to21months.Theinvestigationhasalreadyresultedinover100guiltypleasandconvictionsinthosestates.Notably,JudgeHamiltonoftheU.S.DistrictCourtfortheNorthernDistrictofCaliforniahastakenanarrowapproachtocalculatingthevolumeofcommerceforindividualsentences,findingitshouldbecalculatedtoincludeonlythebidsanagentpersonallybidonandwon.
• Financial Services.Followingrecord-breakingcriminalfinesfrombanksinconnectionwithDOJ’sLondonInterbankOfferedRate(LIBOR)andforeignexchangespotmarket(FOREX)investigationsinpreviousyears,theDOJshifteditsfocustootherbanksandindividualsin2017.InLIBOR,twoSociétéGénéralebankmanagerswereindictedfortheirroleintheconspiracytofraudulentlymanipulatetheLIBORfortheU.S.dollarandseveralothercurrencies.Additionally,DBGroupServices,awhollyownedsubsidiaryofDeutscheBankAG,wassentencedinMarch2017andorderedtopaya$150millionfine.InFOREX,twotraderspleadedguiltyfortheirroleinanallegedconspiracy,andafederalgrandjuryreturnedanindictmentagainstthreeothertraders.TheDOJissettogototrialagainstthesethreeindictedindividualsinJune2018. TheLIBORinvestigationhasinvolvedbothantitrustandfraudcharges,
aswellasparallelproceedingsbyEuropeanauthorities.FollowingconvictionsofseveralindividualsonLIBOR-relatedfraudcharges,theU.S.CourtofAppealsfortheSecondCircuitrecentlyoverturnedthejuryverdictsonthegroundsthatawitnessattrialhadpreviouslyreadtestimonycompelledfromthedefendantsinUKproceedings,inviolationofthedefendants’FifthAmendmentrights.180
• Heir Locators. As discussed previously,theDOJsoughttoprosecuteKemp&Associatesforcollusioninsupplyofheirlocatorservices,butafederalcourtdismissedtheindictment.ThecourtfocusedonwhethertheagreementtheDOJallegedshouldbeanalyzedasperseunlawfulundertheShermanAct.Characterizingtheallegedconspirators’agreementas“uniqueandunusual,”181thecourtdeterminedthatitshouldnotbeviewedasperseunlawfulbutratheranalyzedundertheRuleofReason.Ultimately,however,thecourtfoundthatthecasewasbarredbythestatuteoflimitations;theDOJfiledanoticeofappealwiththeU.S.CourtofAppealsfortheTenthCircuit.
• Public School Buses. Inasmaller-scaleregionalcase,followingaweek-longtrialinJanuary2017,ajuryinPuertoRicoconvictedfourschoolbuscompanyownersofparticipatinginbidriggingandfraudconspiraciesatanauctionforpublicschoolbustransportationservicesinPuertoRico’sCaguasmunicipality.ThisdecisionfollowedacriminalindictmentfiledinMay2015againstfiveindividuals.Thefifthdefendantpledguiltytothechargesbeforegoingtotrial.Nootherchargeshavebeendisclosedsincethattime.
• Obstruction of Justice.TheDOJhascontinuedtovigorouslyprosecuteindividualswhoobstructjusticeduringantitrustinvestigations.Notably,theseindividualsoftenreceiveprisontermsmuchlongerthantheprisontermsimposedforanticompetitiveconductitself.Forexample:
-InFebruary2017,anexecutiveofanautomotivepartscompanypleadedguiltyforhisroleinaconspiracytoobstructjusticeduringthecourseoftheDOJ’sautomotivepartsinvestigation.Theexecutivereceiveda14-monthprisonsentence.
-InMarch2017,aformerCoachUSAexecutivewassentencedto15monthsinprisonforattemptingtoconcealanddestroydocumentsduringthecourseofcivillitigationrelatedtotheNewYorkCityhop-on,hop-offtourbusmarket.
• Diversion of Federal Funds. TheDOJhasbeenactiveinprosecutingindividualsaccusedofmisusingfederalfundsaswell.AssistantAttorneyGeneralMakanDelrahimnotedaboutoneoftheseprosecutionsthatit“demonstrate[d]theAntitrustDivision’scommitmenttopursuingindividualswhoseektoenrichthemselvesbymisusingfederalprogramsattheexpenseoftaxpayers.”182Forexample:
-InApril2017,anofficerofmultipleconstructioncompanieswassentencedtosixmonthsinprisonand24monthsofsupervisedreleasefordefraudingadisadvantagedpersons’businessassistanceprogramoftensofmillionsofdollars.
WSGR 2017 Antitrust Year in Review
19
-InJune2017,aformerexecutiveofanIsrael-baseddefensecontractorwassentencedto30monthsinprisonforhisroleinmultipleschemestodefraudamulti-billiondollarUnitedStatesforeignaidprogram.
-InOctober2017,theDOJindictedaroofingcompanyownerandaformerfacilitiesmanageratSierraArmyDepotfortheirrolesinaconspiracyto divert government funds intendedtorebuildandrepairtheArmyfacilitytothemselvesandtheircompanies.
DOJPolicyInitiativesRevised Leniency Program “Frequently Asked Questions”
OnJanuary26,2017,theDOJupdatedapolicystatementtoitsLeniencyProgram.Thepolicystatementispublishedas“FrequentlyAskedQuestions”(FAQs)totheLeniencyProgram,andthismarkstheDOJ’sfirstrevisiontotheFAQssincetheywereoriginallypublishedin2008.Inissuingtherevisions,theDOJobservedthatmanyoftheresponsestotheFAQsremainunchanged,andthosethatchangedshouldbeviewedas“clarifications”totheLeniencyPrograminlightoftheDOJ’sexperienceoverthelasttenyears.ThenewFAQs,however,containanumberofsignificantupdates.
First,theDOJ’srevisedFAQsstatethatunderacertaintypeofleniencyapplication(referredtoasTypeBleniency),officers,directors,andemployeesmustseparatelyearnimmunity,i.e.,stressingthatimmunityisnotautomaticforemployeesinTypeB leniencyapplications.183Instead,employeesoftheTypeBcorporate
leniencyapplicantwillbetreated“asiftheyapproachedtheDOJindividually”withtheagencyspecificallyreservingtherightto“exercisediscretiontoexclude”themfromleniencyprotection.184ManypractitionersarguedthatthisisasignificantshiftintheDOJ’spractice.185Inpastpractice,theDOJtendedtograntimmunitytoemployeesofaTypeBleniencyapplicantunlesstheemployeewasuncooperativeintheinvestigation.IntheupdatedFAQs,theDOJstressesthatbecauseTypeBleniencyisdiscretionary,itwillconsideranindividual’slevelofcooperationandculpabilitybeforegrantingimmunitytotheindividualemployee,and“highlyculpable”employeesmaybeexcludedaltogether.PractitionersobservedthattheupdatedFAQsthusleftopenthepossibilitythatindividualsworkingfortheleniencyapplicantmayadmitwrongdoingandfullycooperatewiththeinvestigation,butfacecriminalprosecutionnevertheless.186
Second,andrelatedly,theupdatedFAQsprovidefurtherguidanceontheprotectionofacorporateleniencyapplicant’sformeremployees.Previously,theFAQsnotedthatitwas“advisable”forthecorporationtoseekprotectionforformerofficers,directors,oremployees,andindicatedthattheDOJwouldconsideranumberoffactors,including“mostimportantly”theformeremployees’cooperation.187 TheupdatedFAQsnowclarifythatallformeremployeesare“presumptivelyexcludedfromanygrantofcorporateleniency”butintwoscenariostheycanbeofferedprotection:1)wheretheyprovide“substantial,noncumulative”cooperationagainstotherpotentialtargets;and2)wheretheircooperationisnecessaryforthecompanytoadmititscriminalviolation,anenumeratedrequirementundertheLeniencyProgram.Byoutliningthesetwospecificscenarios,thisnewguidancesignalsastricterapproachbytheDOJas
totheeligibilityofanapplicant’sformeremployeesforleniencyprotection.
Third,theupdatedFAQsmakeclearthattheAntitrustDivision’sLeniencyProgramofferscoverageonlyforantitrustcrimesandnottootherpotentialcriminalconduct.ThepreviousFAQsweremoregenerous,offeringpotentialprotectionforcriminaloffensescommitted“inconnectionwith”thereportedantitrustoffense.ThenewFAQsomitthislanguageandinsteadnotethatleniencyprotectionwillnotextendtonon-antitrustcriminalconductunlesssuchconductwas“integral”totheantitrustcrimeitself.Bywayofexample,theDOJnotesinthenewFAQsthat“emailingconspiratoriallysetbids”mightseparatelyalsobemailorwirefraud,buttheapplicantwillnotbeprosecutedforsuchanoffensecommitted“infurtheranceof”theantitrustviolation.ThisexamplestandsincontrasttotheexampleinthepreviousFAQsofacompanybribingaforeignpublicofficial,inviolationoftheForeignCorruptPracticesAct(FCPA),tosteercontractsaspartofabid-riggingconspiracy.ThepreviousFAQsnotedthatifthosebribeswere“inconnectionwith”thebidrigging,thentheleniencyapplicantcouldbecoveredforthatconductaswell.Indeed,theupdatedFAQsspecificallydisavowthisscenario,notingthatbribespaidinviolationoftheFCPAwouldnotbecoveredeveniftheyweredone“infurtheranceof”theantitrustcrime.Inthisway,theDOJsoughttoemphasizethattheLeniencyProgramisdesignedtoofferleniencytoantitrustoffensesonlyandtoclarifythattheDOJdoesnotexpectittobeavehiclebywhichapplicantscanseekimmunityforothercriminaloffenses.
Fourth,theupdatedFAQsaddanewdiscussionoftheDOJ’sPenaltyPluspolicy,whichprovidesthatifacorporationpleadsguiltytoanantitrustcrimeandthen
WSGR 2017 Antitrust Year in Review
20
DOJlaterindependentlylearnsthatthecorporationfailedtoreportitsinvolvementinaseparateantitrustcriminaloffense,theDOJwillseekaharsherpenaltywithrespecttothatnewlydiscoveredoffense.Theseverityofthatpenaltywilldependonthefactsofthecase,includingwhythecorporationfailedtoreporttheseparateoffense,buttheFAQsdonotethatin“egregious”cases,theDOJwouldrecommendfinesatthetoporevenbeyondtheapplicablestatutoryrangeandimpositionofanexternalcompliancemonitoratthecompany.
Fifth,theupdatedFAQsclarifiedthattheDeputyAssistantAttorneyGeneralortheDirectorofCriminalEnforcementmustapprovetheissuanceofleniency“markers,”whichholdpotentialleniencyapplicants’placesinlineforimmunity.ThismakesclearthattheDOJ’sstaffattorneysorsectionmanagementcannotfinallyapprovea“marker”decision.
Inadditiontotheabove,theupdatedFAQsprovideawealthofinformationtocorporationsandindividualsabouttheLeniencyProgram,andcompaniesandcounselshouldreviewtheseFAQsindetailwheneverconsideringapplyingforleniencywiththeDOJ.WhethertheupdatemarksasignificantshiftincertainpracticesorsimplyaclarificationofexistingDOJpracticeremainstobeseenintheyearsahead.
Antitrust Guidelines for International Enforcement and Cooperation
Inearly2017,theDOJandtheFederalTradeCommission(FTC)jointlyreleasedupdatedAntitrustGuidelinesforInternationalEnforcementandCooperation,whichshowthecontinuedpriorityofinternationalcriminalcartelenforcement.Buildingonthepreviousguidelinesfrom1995,thenewguidelines
discusstheDOJ’seffortstocoordinatewithforeignauthoritiesincriminalcartelinvestigations.Consistentwithpastyearsofenforcement,theguidelinesnotethatwhereforeigncompaniesandindividualsareinvolvedinconductaffectingmarketsintheU.S.,theDOJwillnothesitatetorelyonanumberofdifferenttoolstoidentifyandprosecutetheconduct.TheguidelinespointtothenumerousMutualLegalAssistanceTreatiesthatobligateforeignauthoritiestoassisttheDOJingatheringevidenceandservingsubpoenasinforeignsignatoryjurisdictions.
ThenewinternationalguidelinesalsohighlighthowtheDOJworkswithforeigncompetitionauthorities,sharinginformationandattimesconductingjointoperations,suchasonsiteinspections,dawnraids,orsearchestogatherevidenceandavoiddocumentdestruction.TheguidelinesmakeclearthattheDOJexpectscooperatingwitnessesandparticipantsintheLeniencyProgramtoprovidedocumentaryevidenceintheirpossession,custody,orcontrol,evenwhensuchevidencemaybelocatedabroadandoutsidetheDOJ’sordinaryjurisdictionalreach.TheDOJ,inturn,seekstocoordinatewithforeignauthoritiestoavoidoverlappingorinconsistentrequestsanddecreasetheburdenplacedonsuchcooperatorswhereverpossible,pertheguidelines.
TheupdatedinternationalguidelinesmakeclearthattheDOJwilluseallavailabletools,includingissuingINTERPOLRedNotices,todetainfugitiveswhohavebeenindictedincriminalantitrustinvestigationsbutwhohavenotappearedintheU.S.tofacecharges.Thosenoticesmaypromptaforeignjurisdictiontoarrestthefugitiveshouldheorsheenteritsterritory,suchasatanairport.Moreover,buildingontheDOJ’sextraditionsuccessesinthepastdecade,theguidelinesmakeclearthat
theDOJwillseekextraditionoffugitivedefendantsfromforeignjurisdictionstotheU.S.,ifnecessary.
Last,theupdatedguidelineshighlighttheexpansiveapproachtheagenciestaketocommerceoutsideoftheU.S.andthereachofU.S.antitrustlaws.TheDOJconsidersnotonlyimportcommerceaffectedbyantitrustconduct,butalsotheeffectofforeigncommerceincludingsalesoccurringwhollyabroad.UndertheForeignTradeAntitrustImprovementsActof1982(FTAIA)ifthoseforeignsaleshavea“direct,substantial,andreasonablyforeseeable”effectonU.S.commerce,theyfallwithinthereachoftheU.S.antitrustlaws.Asaresult,andtheguidelinesmakeclear,evennon-importcommerceorU.S.exportcommerceimpactedbyapricefixingorotheranticompetitiveagreementabroadcanfallwithinthereachofU.S.antitrustenforcers.Emphasizingthattheanalysisishighlyfactual,theguidelinesgivetheexamplethatsalesofprice-fixedcomponentsabroadthataresubsequentlyintegratedintofinishedproductsimportedintotheU.S.couldverywellhavethedirect,substantial,andreasonablyforeseeableeffectonU.S.commercetobeactionableundertheantitrustlaws.AnotherexamplenotesthatevenproductsaffectedbyanticompetitiveagreementssoldexclusivelyabroadandneverimportedintotheU.S.canbesubjecttoU.S.antitrustlawifthefixedpriceaffectstheworldwideorbenchmarkpriceoftheproductandwherethesameproductissoldintheU.S.bynon-conspirators.Whiletheanalysisisveryfact-specific,theguidelinesindicatethatwhereverthereisevenanindirecteffectofsuchanagreementonU.S.commerce,theagencieswillnothesitatetobringanenforcementactionifnecessary.
WSGR 2017 Antitrust Year in Review
21
Advocacy for Per Se Standard
TheDOJhasrecentlygivenrenewedattentiontotheimportanceoftheperselegalstandardinantitrustcriminalenforcement.188OnSeptember12,2017,AndrewFinch,theActingAssistantAttorneyGeneralatthetime,deliveredaspeechdiscussingtheimportanceofthepersestandardinantitrustenforcement.Inthatspeech,Finchobservedthatthepersestandardprovidesmuch-neededclarityforbusinessesaswellastoregulators.HefurtherdeclaredtheDOJ’scommitmentto“continuetoadvocateforaclearperserule”toapplytoallsortsofagreementsamonghorizontalcompetitors,includingthoseinthelabormarketthatrestrictthehiringorcompensationofemployees.189 Notably,thisspeechfollowedthefederaldistrictcourt’sdecisioninUnited States v. Kemp & Associates.Asdescribedabove,thefederalcourtinthatcasequestionedwhethertheperseruleshouldapplytotheconductatissue,describingtheallegedagreementamongthecompetitorsas“unusual”suchthatitshouldnotbesubjecttoaperseanalysis.
Antitrust Guidance on Disaster Relief Efforts
ManypartsoftheU.S.anditsterritoriesweredevastatedin2017byhurricanesandwildfires.OnSeptember12,2017,theDOJandtheFTCreleasedajointmemorandumprovidingguidanceoncompliancewiththeantitrustlawsinconductingdisasterreliefefforts.Whiletheguidanceismeanttoapplygenerallytovariousconduct,itislargelyfocusedonremindingcompetitorstoavoidimpropercollusion,whichcanleadtocriminalexposure.TheDOJhaspreviouslybeenactiveininvestigatingprocurementfraudandbid-riggingviolationsonitsownandinconnectionwithmulti-agencytask
forces.Withsimilarfocus,theDOJandtheFTCcautionedinthejointmemothatbusinessesshouldavoidpricefixing,bid-rigging,andmarketallocationagreements,andnotedthattheDOJremainedpoisedtocriminallyprosecutesuchviolations.Atthesametime,theDOJandtheFTCrecognizedthattheantitrustlawswere“sufficientlyflexible”andthatcompetingfirmsmayneedtocooperateduringtherecoveryefforts.190Theagenciesstatedthat“jointeffortsoflimiteddurationbybusinessestorestore[critical]servicesmoreeffectivelyandtoassisttheaffectedcommunitiesinrecoveringfromthedevastationmaybebeneficial”andrecognizedhowcompetitorsmayenterintojointventures,jointlicensing,andothercontractualarrangementsduringtherecoveryprocess.Theagenciesnotedhow“[a]ntitrustanalysisofthesecollaborativearrangementscan—andwill—takeintoaccountthechangesinmarketconditionsasaresultofthehurricanes”andsignaledtheircommitmentto“reasonableandresponsible”antitrustenforcementunderthecircumstances.Theguidelinesservedasaremindertocompaniesthatblatantviolationsoftheantitrustlawswouldnotbetolerated,butthattheagenciesrecognizedthedifficultiesinvolvedindisasterrelief,andthefactthatcompetitorsmayneedtocollaborateandsupporteachother’seffortstorebuildandrestoreaffectedareas.
Guidelines for HR Professionals: Criminal Enforcement for Collusion in Labor Markets
Inlate2016,theDOJandtheFTCjointlypublishedapapertitled“AntitrustGuidanceforHumanResourcesProfessionals”(HRGuidance).191ThisHRGuidancehighlightedthatcertainformsofhorizontalcollusionand
informationexchangeswithinthelaborandemploymentcontextcouldviolatetheantitrustlaws.Ofparticularconcerntotheagenciesareinformation-sharingand/oragreementsregardingemployeesalaryorothertermsofcompensation,eitherataspecificlevelorwithinarange(so-calledwage-fixingagreements),orcollectiverefusalstosolicitorhireothercompanies’employees(so-called“nopoaching”agreements).Further,theHRGuidanceservedtoputcompaniesandindividualsonnoticethatDOJmightprosecutesuchconductcriminally.Inthepast,theDOJhasbroughtanumberofcivil“nopoach”casesregardingallegedcollusionbycompaniesinlabormarkets,butnotcriminalcharges.Althoughnocriminalcaseswerefiledin2017,twoDeputyAssistantAttorneysGeneral(AndrewFinchandBarryNigro)commentedpubliclythattheDOJisreadyingcasesregardingsuchagreements.CompaniesthathaveengagedinbenchmarkingstudiesandanalysisorhavetradeassociationparticipationonhumanresourcesissueswillwanttopaycloseattentiontotheDOJ’spursuitinthisspace,particularlygiventhebroadimplicationsforhiringandthesettingofwagesandcompensationinvariouscontexts.
EnforcementAgainstCollusiveConductOutsidetheU.S.CompetitionagenciesoutsidetheU.S.alsocontinuedtobeactiveagainstcollusiveorcartelconductin2017.Whilesomedonotpursuesuchconductcriminally,theygenerallyviewtheconductsimilarlytotheDOJandimposeharshciviloradministrativesanctionsagainstcompaniesengagedinsuchconduct.Belowaresomeofthemorenotableenforcementactionsandpolicyupdates
WSGR 2017 Antitrust Year in Review
22
takenbycertainagenciesagainstcollusiveconduct in 2017.
Canada.TheCanadianCompetitionBureau(CCB)recentlyreleaseda“RevisedImmunityProgram.”Someofthekeyprovisionstotheprograminclude: (i)allowingtheCCBtorecordoralproffersprovidedduringaninvestigation; (ii)reinforcingthatindividualswillnotbeautomaticallycoveredundercorporateimmunity;(iii)introducingan“InterimGrantofImmunity”stageintheleniencyprocessthatclarifiesthatfullimmunityiscontingentoncooperationbytheapplicant;(iv)allowingfortherecordingofwitnessinterviews;and(v)requiringapplicantstodisclosecertaintypesofmaterials,includinginternalinvestigativerecordsunlessprivileged.TheimplicationsforthesepotentialmodificationstotheImmunityProgrammaycomplicatetimingandprocessassociatedwithcross-borderinvestigationsandadduncertaintytodiscoverablematerialstocivilproceedings.
China.CompetitionauthoritiesinChinahaveremainedveryactiveinthepastyear,bringingenforcementactionsagainstcollusiveconductinanumberofindustries.ThisisparticularlynotablegiventhatChina’sprimarycompetitionlawisrelativelynewcomparedtoothercountries(i.e.,China’sAnti-MonopolyLawisinitstenthyear).Chinahasdemonstratedthatitisdevelopingasophisticatedenforcementprograminaveryshortperiodoftime.Asanexample,in2017,oneoftheChineseagenciesresponsibleforenforcingthecompetitionlaws,theNationalDevelopmentandReformCommissionofthePeople’sRepublicofChina(NDRC),imposedfinesonacompanyforobstructingoneofitsinvestigations,markingthefirsttimeacompanyhasbeenfinedforobstructioninacompetitionlawinvestigationinChina.OnFebruary13,2017,theNDRCannouncedthatit,alongwiththelocalbranchofShangdong
PriceBureauandthePriceSupervisionandAnti-MonopolyBureau,finedWeifangLongshunePharmaceuticalRMB120,000forobstructingjustice.Allegedly,certainWeifangemployeesthrewawayUSBflashdrivesandsecretlyreplacedthemduringadawnraid.ThisactionreflectshowChina’scompetitionagenciesareemployingallmeansnecessarytoensuretheintegrityoftheirinvestigations.
European Union. TheEuropeanCommission(EC)haslongbeenactiveinitsenforcementagainstcollusiveconduct.Belowareafewdevelopmentsfrom2017:
• Trucks.InJuly2016,theECimposeditshighestevercartelfine,amountingtoapproximately$3.2billion,onseveraltruckmanufacturersforalong-standingcartelthataffectedthemajorityoftruckssoldintheEuropeanEconomicArea(EEA)between1997and2011.192InSeptember2017,anadditional$1billionwasimposedonafifthtruckmanufacturer,Scania,thatrefusedtosettlewiththeECandcontestedthecharges.193 Aside fromthe$4.2billionaggregatefine,thecartelistsfacetheprospectofsignificantprivatedamagesclaimsbeforenationalcourtsgiventhescopeofthecartel.UndertheEUDamagesDirective,claimantscannowrelyonthefinaldecisionofacompetitionauthorityasprimafacieevidenceofaninfringement,makingiteasiertobringfollow-ondamagesclaimsandpotentiallymakingcartelconductconsiderablymorecostly.SeveralclassactionsandindividualclaimsareongoinginIreland,Germany,theNetherlands,andtheUK.
• Automotive Industry.Therehavebeenwide-rangingautomotivepartscartelinvestigationsbytheECin
recentyears,andtheECissuedfourinfringement decisions in 2017:
-InFebruary2017,a$75millionfinewasimposedforanticompetitivepracticesconductedbyaso-called“buyer’scartel.”Unlikemostcartelparticipantswhocolludetoincreasetheirsaleprices,inthiscasefourrecyclingcompaniescolludedtoreducethepurchasepricepaidtoscrapdealersforrecycledcarbatteries.194
-InMarch2017,sixcarairconditioningandenginecoolingsupplierswerefinedatotalof$163millionfortheirparticipationinfourdifferentcartelsfocusedonthecoordinationofpricesandmarketsaswellastheexchangeofcompetitivelysensitiveinformation.195
-InJune2017,theECimposeda$30millionfineontwocompanies,HellaandAutomotiveLighting,forcoordinatingtheirpricingstrategiesforthesaleofvehiclelightingsystemstocarmanufacturers.Athirdcompany,Valeo,receivedimmunityfordisclosingthecarteltotheEC.196
-InNovember2017,theECfinedfivecarsafetyequipmentmanufacturers$40millionfortheirparticipationinfourdifferentcartels.Thecartelaffectedsalesofseatbelts,airbagsandsteeringwheelstoJapanesecarmanufacturersToyota,Suzuki,andHonda.197
WSGR 2017 Antitrust Year in Review
23
• Airfreight.InNovember2017,theEuropeanCourtofJustice(ECJ),theEU’shighestcourt,confirmedafineimposedonBritishAirwaysforparticipatinginapricefixingcartelforfuelandsecuritysurcharges.198 BackinNovember2010,theECfined11airlines$1.1billionforsuchconduct,howevertheGeneralCourt(GC)overturnedthefinein2015onproceduralgrounds.199Unliketheotherairlinesinvolvedintheappeals,BAhadsoughtonlyapartialannulmentofthedecision.Asthe2015reversaldidnottouchuponthesubstantiveissuesofthecase,theECdidnotappealandinsteadadoptedanewcorrecteddecisioninMarch2017thatre-establishedfinesofapproximately$829million.200Thematterisnotover;severalappealsagainstthesecondECdecisionarenowpendingbeforetheGC.201
• Cathode Ray Tubes.OnSeptember14,2017,theECJrejectedappealsbroughtbyLGandPhilipsagainsttheGC’s2015judgments,whichhadconfirmedtheEC’s2012infringementdecisioninthecathoderaytubecartels.202Thetwocartelsconsistedofpricefixing,allocationofmarkets,customersandsalesvolumesandimproperexchangesofinformation.Indismissingtheappeal,theECJprovidedusefulguidanceontwoissues:(1)“valueofsales”includessalesoffinishedproductsincorporatingthecartelizedproductsintheEEA,evenwhentheproductwassoldfirsttoentitiesoutsidetheEEAviaintragroupsales;and(2)salesofcartelizedproductsbetweenajointventureanditsparentswillbeconsideredas“intragroupsales”whichcanbetakenintoaccountbytheECforthecalculationoffinesfortheentiregroup.
• New EC Whistleblowing Tool. Untilnow,mostcartelsintheEEAweredetectedthroughtheEC’sleniencyprogram,whichallowedcompaniestodivulgetheexistenceofacartelandadmittheirparticipationthereininexchangeforimmunityorareductioninfines.InMarch2017,theECintroducedanewwhistleblowingtoolthatenablesindividualswhomighthaveinformationregardingtheexistenceofasecretcartel(orothertypesofantitrustviolations)toanonymouslyinformtheEC.203ThisnewtoolunderlinestheneedforcompaniestohavetheirowninternalcompliancereportingtoolssothatemployeescanraisepotentialantitrustviolationsinternallyinsteadofescalatingthematterthroughtheEC’swhistleblowingtool. Japan.TheJapanFairTradeCommission (JFTC) continued its aggressiveenforcementregardingcollusionin2017aswell.Inthelastyear,therehavebeenacoupleofnotabledevelopmentsthatcouldsignificantlyaffecthowcompaniesapproachinvestigationsofpotentialcollusion.
•First,onApril25,2017,theJFTCpublishedareportfocusingonthecurrentsurchargesystemofimposingfinesundertheAntimonopolyAct,andproposingcertainrevisionstothesystem.Thecurrentsystemprovidesleniencyapplicantsautomaticdiscountsoncetheinitialeligibilitycriteriabytheapplicantaresatisfied.TheJFTCisnotaffordedthediscretiontoadjustthesurchargeorleniencybenefitsaccordingly,whichitisreportedmaynotprovideanincentiveforapplicantstocontinuecooperationintheinvestigation.Theproposed
revisionstothesurchargesystemwillprovidetheJFTCwithmoreflexibilityanddiscretiontoimposesurchargepaymentstomotivateanapplicanttocooperatethroughouttheinvestigation.
•Second,inthesamereport,theStudyGroupontheAntimonopolyActfurtherdiscussedwhethertorecognizecertainlegalprivilegesinJFTCinvestigations.InJapan,theattorney-clientandattorneyworkproductprivilegesarenotrecognizedasbroadlyasinotherjurisdictions.Therehasbeenanongoing discussion since 2014 of introducinglegalprivilegesintheJFTCinvestigations,andin2017theStudyGroupreexaminedtheissue.TheStudyGroupobservedthatundertheproposedrevisedleniencysystem,consultationwithattorneyswouldbecomeindispensableforleniencyapplicantsifcontinuouscooperationisincentivized.Withouttheprivilegeprotection,leniencyapplicantsmightdeterconsultationwithattorneysandrestrainthefact-findingeffortsduringtheinvestigation.TheStudyGroupconcludedthatitisanoteworthyconcern,andwilltaketheissueintofutureconsideration. South Korea.TheKoreanFairTradeCommission(KFTC)strengtheneditsenforcementprogrambyintroducinganamendmenttoitscompetitionlawsthatwouldincreasethefinancialpenaltiesforlong-termorrepeatviolations.Specifically,theamendmenttotheMonopolyRegulationandFairTradeActandNotificationonImpositionofPenaltySurchargewouldallowtheKFTCtoincreasetheadministrativefinesforillegalanticompetitiveconductwithanadditionalmultiplierofupto
WSGR 2017 Antitrust Year in Review
24
ThisYearinShermanActSection1and2LitigationThisyear,large-scalecivilantitrustlitigationcontinuedtobeextremelyactive,withdevelopmentsinbothSection1andSection2cases.Casesinvolvingallegationsofcompetitoragreementsand/orothercollusionhavebeenbroughtagainstcompaniesintechnology,chemicals,electronics,andpharmaceuticalsectors.Thesecasesaretypicallybroughtonbehalfofpurchasersinfederalclassactions,aswellasbycompetitorsorotherentitiesinnon-classcases.Manyofthemostsignificantcasesare“followon”civildamageclassactions,i.e.,arecasesseekingmonetarydamagesthatfollowgovernmentantitrustenforcementactionsorinvestigationsbytheU.S.DepartmentofJustice(DOJ)ortheFederalTradeCommission (FTC).
Price-Fixing Litigation
U.S. Supreme Court Petition. In 2017, theU.S.SupremeCourtsolicitedviewsonwhetheritshouldhearargumentinthelong-runningVitaminCcase,inwhichSection1claimswerebroughtagainsttwoChinesemanufacturersforanallegedconspiracytofixthepricesandoutputofVitaminC.207LastSeptember,inanimportantdecisionregardingcomitybetweenU.S.andforeignlaws,theU.S.CourtofAppealsfortheSecondCircuitvacateda$150millionjuryverdictagainstthetwoChinesemanufacturers.208 ThepanelrecognizedtheChinesegovernment’sofficialstatementthatChineselawcompelledtheconductatissue.Findinga“trueconflict”betweenAmericanandforeignlaw,thecourtdismissedthecaseunderthedoctrineofinternalcomityandrecognizedthatthisdisputewouldbetterberesolvedbytheexecutivebranch.DirectpurchaserplaintiffspetitionedtheSupremeCourtto
hearthecasearguingthattheSecondCircuit’scompletedeferencetotheChinesegovernment’sinterpretationofitslawscreatesacircuitsplitwiththeFifth,Sixth,Seventh,Eleventh,andD.C.Circuits,wherecourtsmayexerciseindependentreviewofaforeigngovernment’sinterpretationofitslaws.
Attheendofthe2016term,theSupremeCourtcalledfortheviewsoftheSolicitorGeneral,whoagreedthattheCourtshouldgrantcertioraritoreviewwhethertheSecondCircuitgavethecorrectdeferencetotheChinesegovernment’sofficialstatement.TheCourtshoulddecideinearly2018whethertotakethecase.ShouldtheCourtgrantcertiorari,WSGRpartnerJonathanJacobsonwillbearguingthecaseonbehalfoftheChineseVitaminCmanufacturers.
Oligopoly Markets.AmongthemoresignificantantitrustdecisionsoftheyearwastheU.S.CourtoftheAppealsfor
80percentforeitherlong-termorrepeatviolations.Ifbothconditionsofviolationshaveoccurred,thentheincreasecanbeupto100percentincreaseofthebasefinecalculation.Previously,theincreasetothebasefineforlongtermorrepeatviolatorswasonlybyafactorof50percent.TheenactedamendmentnowallowstheKFTCtoimposeahigherincreasetothefineinanefforttodeter recidivism. United Kingdom. Attheendof2016,theUK’sCompetitionand
MarketsAuthority(CMA)disqualifiedthemanagingdirectorofTrodLimited,anonlinepostersupplier,forfiveyearsinconnectionwiththeprosecutionofanonlineposterscartel,whichservesasareminderthatsomejurisdictionsdomorethanseekfinesandjailsentences.204 In2017,theCMAalsopublishedawarninglettertocompaniesinthe“creativeindustries”remindingthemthat,intheUK,themeresharingofsensitiveinformationbetweencompetitorscanviolatethecompetitionlaws.TheCMAissued
thisletterbecauseitperceivedthatknowledgeofcompetitionlawinthatsectorwasespeciallypoor.205TheCMAletterfollowedtheCMA’sinvestigationintoacartelinvolvingfivemodelagencies,inwhichtheCMAimposedfinestotalingapproximately£1.5million(approximately$million)betweenApril2013andMarch2015.206 In additiontocautioningagainstpricefixing,theCMA’sletterremindedbusinessesthattheCMAwillnottolerateeventhesharingofsensitiveinformation.
CivilLitigation
WSGR 2017 Antitrust Year in Review
25
theThirdCircuit’saffirmationofsummaryjudgmentinfavorofdefendantsinValspar Corp. v. E. I. Du Pont De Nemours & Co.209 Thiscasefocusedonanoligopolisticmarket,i.e.,oneinwhichasmallnumberoffirmsdominatethemarket.TheThirdCircuitheldthat,inanoligopolisticmarket(inthiscase,titaniumdioxide),proofofparallelpriceincreasesandlimitedcircumstantialevidencewasnotsufficientevidencetoestablishSection1price-fixingallegations.Ingrantingsummaryjudgment,thecourtexplainedthatthedemonstratedparallelpriceincreaseswereanexampleof“consciousparallelism,”atheorythatpartiesinanoligopolisticmarketwillraisepricesinresponsetorivalpriceincreases,ifitisbelievedthatdoingsowillmaximizeindustryprofits.Such“parallelism,”however,caninvolveunilateraldecisionandmaynotindicateanyactualcoordinationoragreementtoincreasepricesamongcompetitors.Thecourtthereforefoundthattheplaintiffsfailedtoshowevidenceofanagreementtoraisepricesamountingtoaconspiracy.EspeciallyintheThirdCircuit,whichhasbeenanactivevenueforantitrustlitigation,theValspardecisionisnoteworthybecauseitraisesthebarforaplaintifftoestablishanantitrustprice-fixingclaiminanoligopolisticmarket,absentdirectevidenceofanunlawfulagreement.
Antitrust and Arbitration Clauses.Inaprice-fixingcaseinitiallybroughtagainstUber’sthenfounder,TravisKalanick,andUberdrivers,theU.S.CourtofAppealsfortheSecondCircuitreversedthelowercourt’sdecisionandheldthatUber’stermsofservicerequireconsumerstoarbitratealldisputesbeforeproceedingwithacourtaction.210ThepanelwasconvincedthatconsumersweresufficientlyonnoticeofUber’stermsofservice,whichincludedanarbitrationprovision,basedonthewarningtextusedontheregistrationscreen.Thiscasefollowsafteralonghistoryoflitigationreflectingatensionbetweenupholding
contractualarbitrationclausesandtheabilitypartiestoseekdamagesviacivilclassactions,includingIn American Express Co. v. Italian Colors Restaurant,211 inwhichtheU.SSupremeCourtheldthatanarbitrationprovisioncouldnotbeoverturnedevenifanarbitrationwouldcostpotentialplaintiffsmorethantheycouldrecoverindamages.ManyofWSGR’stechnologyandotherclientsoftenarecalledtodefendtheirtermsofserviceincourt,andthus,theSecondCircuit’sdecisionheremaybefavorableprecedentinfuturedisputes.
Pharmaceutical “Follow-On” Litigation. Sincethebeginningoftheyear,thealreadyexpansivelitigationagainstgenericdrugmanufacturers,In re Generic Pharmaceuticals Pricing Antitrust Litigation, hasgrownevenfurther.Theselarge-scaleclassactioncaseswerefirstfiledbyprivateplaintiffpurchasersinparallelwithongoinginvestigationsbytheDepartmentofJusticeandtheStateAttorneyGeneralforConnecticut.InApril2017,theJudicialPanelonMultidistrictLitigation(JPML)consolidatedapproximately70casesagainstthedrugmanufacturersandtransferredallactionstoJudgeCynthiaRufeintheU.S.DistrictCourtfortheEasternDistrictofPennsylvania.212 After consolidation,theprivateplaintiffsinthemulti-districtlitigation(MDL)filedamendedcomplaintsinAugust2017allegingproduct-specificconspiraciesconcerning18drugs:albuterol,amitriptyline,baclofen,benazeprilHCTZ,clobetasol,clomipramine,desonide,digoxin,divalproexER,doxycycline,econazole,fluocinonide,glyburide,levothyroxine,lidocaine/prilocaine,pravastatin,propranolol,andursodiol.Forpurposesofmotiontodismissbriefing,thecourtdividedthe18drugsintothreegroupsofsixdrugs.Motionstodismissclaimsallegingprice-fixingconspiraciesastothefirstgroupofdrugwerefiledinOctober2017,oppositionbriefswere
filedinDecember2017,andreplybriefsaredueinJanuary2018.Themotionswilltestthesufficiencyofthecomplaints,andtheissuesraisedintheValspar decision discussedabovewillberelevanthere.Motionstodismissfortheothergroupswillbefiledlaterin2018.
InDecember2016,attorneysgeneralfrom20statesfiledacomplaintwiththeU.S.DistrictCourtfortheDistrictofConnecticutregardingtwodrugs—aformofdoxycyclineandglyburide.TheJPMLconsolidatedthisaction(whichhadgrowntoincludeoverfortystateattorneysgeneral)withtheclassactionsintheMDLinAugust2017.AttheendofOctober,thestateattorneysgeneralmovedforleavetofileanamendedcomplaintpurportingtoexpandtheircomplainttoincludethirteenadditionaldrugs(noneofwhicharecurrentlyatissueinanyoftheclassactionsuits)andaddingnumerousadditionaldefendants.Notably,theattorneysgeneralproposetoallegeanoverarchingconspiracycoveringmultipledrugs,whereastheprivateplaintiffshavemaintainedindividualdrug-specificactions.Briefingonwhetheramendmentwillbepermittedwillextendinto2018.WSGRiscurrentlyrepresentingMylaninthislitigation.
FTAIA: Litigation Involving Overseas Parties and Commerce.FederalcourtlitigationregardingtheextraterritorialreachofU.S.antitrustlawsincivildamagescasescontinues.Thissubjectmattersinantitrustcaseswhereabroadscopecoulddrawinnon-U.S.defendantsandsignificantnon-U.S.salesorcommerceasdamagesintoaU.S.classactioncase.Inrecentyears,multiplecaseshavebeenarguedinfederalCourtsofAppeal,withafocusontheinterpretationoftheForeignTradeAntitrustImprovementAct(FTAIA).TheFTAIAputslimitsonthereachofU.S.lawtocasesthatprimarilyconcernforeigncommercethatdoesnotdirectlyimpactU.S. consumers.
WSGR 2017 Antitrust Year in Review
26
Towardstheendof2016,JudgeJamesDonatooftheU.S.DistrictCourtfortheNorthernDistrictofCaliforniaissuedacriticaldecisioninterpretingthecurrentstateofFTAIA.InIn re Capacitors Antitrust Litigation,aSection1classactionlitigationfollowinganumberofinternationalcriminalinvestigationsintoanallegedcartel,JudgeDonatoorderedthatasamatteroflaw,damagesarenotrecoverableonpurelyforeigntransactions(i.e.,transactionsbilledtoandshippedtocustomerslocatedoutsideoftheU.S.)wheretheplaintiffsareclaimingthatforeigncapacitormanufacturersimplementedglobalpricingincreases.213Soonafterthecourt’sorder,allofthepartiesstipulatedthatpurelyforeigntransactionsareexcludedfromthecase.Forthemajorityofthedefendantsinthisclassactionandotherclassactionsinvolvingoverseasconductandparties,includingWSGRclientHitachiChemicalCo.,Ltd.,thisrepresentsasubstantialvictorybecausemorethan90percentofthecapacitorsalestheymadeduringtherelevanttimeperiod(2003-2014)couldnotbeclaimedasdamages.
Monopolization and Single-Firm Conduct Litigation
In re Photochromic Lens Antitrust Litigation. ThisyearbroughtthesuccessfulconclusionofamultiyearMDLfacedbyTransitionsOptical,Inc.(TOI),whichwasdefendedbyWSGR.FollowingaconsentdecreewiththeFTCregardingTOI’sloyaltydiscountsandexclusivedealingforlens-relatedproducts,morethan30lawsuitswerebroughtbyprivateplaintiffs,includingclassactionsonbehalfofdirectandindirectpurchasers,aswellasasuitbroughtbyacompetitor(Vision-EaseLensWorldwide).214
Bothdirectpurchasers215andindirectpurchasers216failedtoobtaincertificationoftheirproposedclassesbasedonextensiveeconomicexpertanalysisdone
byallsides.Ultimately,TOIwasabletodemonstratethattheclassplaintiffscouldnotshowhigherclass-wideprices,andthatconflictsofinterestbetweentheclassmemberswhobenefitedfromtheallegedexclusionarypracticesandthosethatclaimedtohavebeenharmedmeantthattheclassrepresentativescouldnotfairlyandadequatelyrepresenttheproposedclasses.217Thisquestion—whetheraproposedclasscanshowpredominance—arisesineveryantitrustclassactionandrequiresspecializedexpertisebyboththecounsellitigatingthecaseandeconomicexpertscalledupontoanalyzedata,performregressionanalyses,andopineonhighlycomplexstatisticalmodels.
Afterclasscertificationwasdeniedforboththedirectandindirectpurchasers,thelitigationwastransferredtotheU.S.DistrictCourtfortheDistrictofDelawareforresolutionofcompetitorplaintiffVision-Ease’sclaimsagainstTOI.Afteradditionalexpertdiscoveryandbriefing,thecourtfoundthatTOIwasentitledtosummaryjudgmentonVision-Ease’srefusaltodealclaim,duelargelytoTOI’sdemonstrationofitswillingnesstocontractwithVision-EaseandVision-Ease’sfailuretopursuetherelationship.218
PriortoatrialthatwassetforJune2017concerningasingleremainingclaimonexclusivedealingallegations,TOIandVision-Easereachedasettlementtoresolvethelitigation.ThesettlementallowedTOItoavoidfacingajurytrialoncausesofactionforwhichtheplaintiff,Vision-Ease,claimedhundredsofmillionsindamages.
Continuing Litigation Regarding Exclusivity and Exclusionary Conduct.In2017,therewerealsoseveralfederalcourtcasesinwhichdistrictcourtswereunwillingtodismissantitrustcases.InComplete Entertainment Resources LLC v. Live Nation Entertainment, Inc. et al,219the
districtcourtdeniedLiveNationandTicketmaster’smotionforpartialsummaryjudgmentinasuitbroughtbySongkick,aconcertticketingstart-up.Songkickhasallegedavarietyofantitrustviolations,includingamonopolizationclaimunderSection2oftheShermanAct,stemmingfromTicketmaster’scontractswitheventvenues.
Songkick’sbusinessmodelreliedon“providingeventticketingservicesfor‘artistpresales.’”220However,Ticketmasterarguedits(typicallymultiyear)exclusivecontractswithvenuesgaveit“exclusiveticketingrightstoallticketsatthatvenue,includingartistpresales.”221Songkickallegedthatartistshavehistoricallyexpectedacertainvolumeofpresaleticketsthattheycouldcontrolanddistributetofansandpresentedevidencethat“artistsprefertopurchaseticketservicingonanentiretourbasis.”222 As such,accordingtoSongkick’sallegations,Ticketmaster’s“overwhelmingmarketshare”allowsittoexcludeSongkickfrompresalesatvenueswithcontractswithTicketmasterandthusrendersSongkick“effectively...unabletoacquireanybusinessfromartistsforthepresaleticketingservicingneeds.”223
Thecourtfoundthatthereis“noquestion”thatarestraintoftradeisatissueinthelitigation,andstatedforTicketmastertowinatsummaryjudgment,itwill“essentiallyneedtoshowthat[p]laintiffhasfailedtomeetitsburdentoshowananticompetitiveeffectderivedfromtherestraintsatissueeitherasamatterofevidentiaryproductionorasamatteroflaw.”224
Similarly,inarecentdecision,theU.S.DistrictCourtfortheSouthernDistrictofNewYorkissuedanorderdenyingKeurigGreenMountain,Inc.’smotiontodismisstheMDLantitrustclaimsbroughtbydirectpurchasersofK-Cupcoffee
WSGR 2017 Antitrust Year in Review
27
pods.225Thecommonallegationsacrosstherespectiveplaintiffs’complaintsincludeclaimsthatKeurigforceddistributorsintoexclusiveagreements,improperlyacquiredcompetitors,engagedinshamlitigation,andattemptedtopreventcompetitorsfromenteringthemarket.226 Immunity from Antitrust Liability
Courtscontinuetoexploretheboundariesofimmunitydefensestoantitrustclaims,includingcircumstancesinwhichpartiesareimmunebecausetheyarepetitioningthegovernment(NoerrPenningtondoctrine),filedrateandotherregulatorydoctrines,andsports-relatedantitrustimmunity.
Noerr-Pennington Doctrine. Thispastyear,theNoerr-Penningtondoctrinehasfrequentlybeenusedasadefenseinantitrustlitigationwithvaryingdegreesofsuccess.TheNoerr-Pennington doctrine shieldspartiesfromantitrustclaimswhentheypetitionthegovernmenttotakeaposition.WSGRsecuredanimportantvictoryforAmphastarPharmaceuticals,Inc.inonesuchmatter,Amphastar Pharmaceuticals Inc. v. Momenta Pharmaceuticals, Inc.Amphastar,amanufacturerofgenericenoxaparin,allegedthatitscompetitorsMomentaPharmaceuticals,Inc.andSandozInc.violatedtheShermanActwhenitmisledastandards-settingorganizationcalledtheU.S.PharmacopeialConventionanditsmembersintoadoptingamethodfortestingenoxaparin,ananticoagulantdrug,bynotdisclosingapendingpatentapplicationpotentiallycoveringthattestingmethod.Afterthemethodbecamethestandard,enoxaparinmanufacturerslikeAmphastarallegedthattheywererequiredtouseitfortheirAbbreviatedNewDrugApplication(ANDA)submittedtotheFDA.ShortlyaftertheFDAapprovedAmphastar’sANDA,MomentaandSandoz
suedAmphastarforpatentinfringementandobtainedatemporaryinjunction,whichdelayedAmphastar’sentryintothegenericenoxaparinmarket.
Intheantitrustlitigation,MomentaandSandozarguedthatanydamagesAmphastarsufferedresultedfromthepatentlitigationandthus,theyareimmunefromliabilityunderNoerr-Pennington. ThedistrictcourtagreedanddismissedAmphastar’scomplaintonthisbasis,buttheFirstCircuitreversedholdingthat,“Themereexistenceofalawsuitdoesnotretroactivelyimmunizeprioranti-competitiveconduct.”227Thepanelwentontoobserve,“Inessence,themerefactthatthedefendantsbroughtprotectedpatentlitigationagainstAmphastardoesnotimmunizethemfromliabilityforthefullamountofdamagescausedbytheirallegedantitrustviolation.”228TheFirstCircuitremandedthecasebacktothedistrictcourt,whereadditionalmotiontodismissbriefingispending.
InadditiontotheAmphastarmatter,therewereother importantNoerr-Pennington decisions in 2017. In Polaris Innovations Ltd. v. Kingston Technology Co., Inc.,theU.S.DistrictCourtfortheCentralDistrictofCaliforniadeniedSamsung’smotiontodismissKingston’santitrustcounterclaimsarguingthattheywerebarredunderNoerr-Pennington.229KingstonclaimedthatSamsungfundedPolaris’acquisitionofpatentssoitcouldthenbringshampatentlitigationagainstanyinfringerandbasedonthisshamlitigation,Kingstonsufferedantitrustinjuries.InrejectingSamsung’sargument,thecourtheldthatNoerr-Pennington doesnotapplytoshamlitigation.Butontheotherhand,theFederalCircuitaffirmeddismissalofantitrustclaimsallegingthatSNFfiledbad-faithlitigationagainstitscompetitorstogainmonopolypowerinIndustrial Models, Inc. v. SNF, Inc.230TheFederalCircuitfoundthatIndustrialMotorsfailedtoshow
thatSNFengagedinobjectivelybaselesslitigationorthatSNFengagedinapatternofshamlitigation.231
Filed-Rate Doctrine. Animportantchallengetotheapplicationofthefiled-ratedoctrineiscurrentlypendingbeforetheU.S.SupremeCourt.Thefiled-ratedoctrinegenerallyprotectscarriersfromantitrustlitigationregardingratesthathavebeensubmittedandapprovedbyfederalregulatoryagencies.232Earlierthisyear,theU.S.CourtofAppealsfortheNinthCircuitheldthatthreeairlines(AllNipponAirways,ChinaAirlines,andEvaAirways)cannotescapeanactionalleginganticompetitiveratesthatwerenotfiledwiththeU.S.DepartmentofTransportation(DOT)(e.g.,fuelsurchargesanddiscountfares)underthefiled-ratedoctrine.233Theairlinesarguedthatthesefaresshouldstillbecoveredunderthefiled-ratedoctrinebasedontheDOT’splenaryregulationofairlinefaresandsurcharges,butthepaneldisagreed,notingthatonlythosefaresactuallyfiledwiththeDOTwouldbeexemptfromantitrustclaims.TheairlinesappealedthedecisiontotheSupremeCourtarguingthatthedecisionbelowtramplesontheagencies’exclusiveregulatorypowerandcouldhavesignificantimpactbeyondtheairlineindustryincludingtheenergy,telecommunications,andinsurancesectors.234TheCourtislikelytodecidewhethertohearthecaseinmid-2018.
Sports Litigation. Anotherhistoricalareaofimmunityfromantitrustclaimsarisesinsportscontexts,includingtheSupremeCourt’srecognitionina1922casethatCongressdidnotintendtoregulateprofessionalbaseballundertheantitrustlaws.235Courtshavewrestledwiththisholdingeversince,buthaveultimatelyfoundthatanychangetotheexemptionmustcomefromCongress.MajorLeagueBaseball’s(MLB’s)antitrustexemptionwasunsuccessfullychallengedonnumerous
WSGR 2017 Antitrust Year in Review
28
occasionsin2017,includinginaSection2caseagainsttheChicagoCubs,broughtbybuildingownerswhoseviewofgameswasobstructedbynewvideoboards.236 TheU.S.CourtofAppealsfortheSeventhCircuitaffirmeddismissalofthecasepursuanttotheantitrustexemption.Intwoothercasesbroughtin2017byminorleagueplayersandscouts,allegingsuppressedwages,theNinthCircuitandSecondCircuitrejectedargumentstooverturntheexemption.237ItisunlikelythatprivatelitigantswillsurmountMLB’santitrustexemptionincourt,butinsteadwillhavetopetitiontheirlawmakersforanymeaningfulchangetooccur.
Trends in PharmaceuticalLitigationLitigationrelatedtopharmaceuticalissuesisoneofthefastestgrowingandmostquicklyevolvingareasoflaw.Thereareseveraltypesofantitrustclaimsthatareuniquetothepharmaceuticalsector,andthesecasesareparticularlycomplexduetoFDAandgovernmentregulatoryrequirements,aswellaspatentandintellectualpropertyrightsthatareoftenimplicated.In2017,anumberofdevelopmentsareworthnotingconcerning:(1)“pay-for-delay”or“reversepayment”casesinwhichcompaniessettlepatentlitigationswithanagreementtodelaygenericentry;and(2)casesinwhichgenericdrugmanufacturerscryfouloverallegedtacticsusedbymarketparticipantstodelayorforecloseentry.
Pay-for-Delay
TheU.S.SupremeCourt’s2013decisionin FTC v. Actavis,238holdingthatreverse-paymentagreementscanviolateantitrustlawsincertaincircumstances,spurredanumberofprivateandgovernmentreverse-paymentlitigationsinrecentyears.
Areversepaymentoccursinapatentlitigationwheretheplaintiffmanufacturerofabrand-namedrugagreestocompensateoneormoremanufacturersofthedefendantgenericdrugs(theallegedinfringers)inexchangeforapromiseofdelayedgenericentryinthemarket.TheSupremeCourtheldthatsuchagreementscanbeunlawfulifthecompensationwas“largeandunjustified”andresultsinharmtocompetition.
First Pay-for-Delay Jury Trial.Sincethe2013 Actavisdecision,plaintiffsinpay-for-delaycaseshavefacedanumberofobstaclesinlowercourts.InIn re Nexium Antitrust Litigation,theonlypay-for-delaycasetriedtoajuryverdictthusfar,defendantsprevailedafterthejuryfoundthatplaintiffsfailedtoproveantitrustinjury(actualharmcausedbythedefendants’conduct),eventhoughthereversepaymentsettlementitselfwasfoundtobeanticompetitive.Specifically,thejuryconcludedthateveniftheanticompetitivesettlementhadnotoccurred,genericentrystillwouldnothaveoccurredanysooner,whichmeantplaintiffswerenotinjuredbythesettlement.Nexiumplaintiffs’2016appealand2017requestforhearingenbancbeforetheU.S.CourtofAppealsfortheFirstCircuitfailedaswell.239
Highly Fact-Specific Inquiries Post-Actavis. Other2017casesillustratethatthesuccessofapay-for-delayclaimunderfederalantitrustlawsisahighlyfactualinquiry,onissuessuchascausationofantitrustinjuryandthevalidityoftheunderlyingpatent.In re Lidoderm Antitrust Litigation,240amultidistrictlitigationbeforetheU.S.DistrictCourtfortheNorthernDistrictofCalifornia,isacasetowatchasitheadstotrialin2018.InNovember2017,thedistrictcourtdenieddefendants’motionforsummaryjudgment,rulingthereisenoughevidencethatgenericentrycouldhavehappenedsoonerhaddefendantsnotsettledtheirpatentlitigation
witha$266millionreversepayment.Intheirmotionforsummaryjudgment,LidodermdefendantsunsuccessfullyarguedthatplaintiffsmustprovedefendantWatson,thepharmaceuticalcompanywhosoughtgenericentry,wouldhavewonthepatentlitigationhaddefendantsnotsettled.Thecourtdisagreed,callingdefendants’positionthatthepatentlitigationbere-litigatedwithintheantitrustcasea“turducken”thatis“notonlyunappetizingasamatterofjudicialefficiency”butalso“notrequired(orevensuggested)bytheActavisopinion.”241 Todefeatsummaryjudgment,thecourtstated,itissufficientthatplaintiffsputforth“someevidence”thatthegenericcouldhavewonthepatentlitigationoronappealbeforetheFederalCircuit,aburdenthatLidodermplaintiffshavesatisfied.242
In re Lidodermhighlightsthatakeyissueinpay-for-delaycasesisthevalidityofthepatentunderlyingthepatentlitigationthatgaverisetothereversesettlementatissue.Forexample,inIn re Wellbutrin XL Antitrust Litigation,theU.S.CourtofAppealsfortheThirdCircuitaffirmedthatplaintiffsfailedtoallegestandingintheformofanticompetitiveharmcausedbydelayedgenericentryasaresultofthereversepaymentagreementatissue.Wellbutrin defendantssuccessfullyraisedpatentvalidityasadefensebyshowingthat,becauseakeypatentunderlyingthechallengedsettlementagreementwaslikelytobefoundvalid,genericcompetitorswouldnothavebeenabletotheenterthemarketanywaybeforethepatentexpired.243
Butforplaintiffsinpay-for-delaycaseswhowanttoarguepatentinvalidityintheThirdCircuit,theyshouldbewarethatatleastonedistrictcourthasruledplaintiffscouldnotusethefactthatapatentwasfoundinvalidpost-settlementtosupportafindingthatthereversepaymentatissuewasanantitrustviolation,244consistentwiththe
WSGR 2017 Antitrust Year in Review
29
generalapproachthatinpay-for-delaycases,thecourtevaluatesthereversepaymentsettlement’sreasonablenessatthetimeitwasenteredinto.
Pleading Causation. In re Actos End-Payor Antitrust Litig.245demonstratesthatinpay-for-delaycases,pleadingcausationwithsufficientfactualallegationscanmakeorbreakplaintiffs’survivalofamotiontodismissforfailuretostateaclaim.There,theU.S.CourtofAppealsfortheSecondCircuitrevivedaproposedclassactionbypurchasersofActos(adiabetesdrug)butlimiteditsscope,allowingplaintiffstopursuetheirallegationsthatdefendantTakedadelayedgenericdrugmakerTeva’smarketentry,butnottheentryofanyothergenericdrugmaker.
ThedistrictcourtinIn re Actoshaddismissedthecomplaintin2015afterfindingplaintiffpurchasersdidnotplausiblyshowthatTakeda’sactionsdelayedgenericversionsofActosfromenteringthemarket.WiththeexceptionofTeva,theSecondCircuitagreedwiththelowercourtthatplaintiffs’theoryofdelayedgenericentryisimplausiblebecauseitrestsonthegenericdrugmakershavingknowledgeofTakeda’sdescriptionofitspatentsbeforetheFDA—apremisethatisnecessarybutnotsupportedwithsufficientfactualallegationsinthecomplaint.246Plaintiffs’theorywithrespecttoTeva’sdelayedentry,however,didnotdependonTevahavingsuchknowledgeofTakeda’sconduct,andwasconsidered“highlyplausible”bytheSecond Circuit.247
DefendantsinIn re Loestrin 24 Fe Antitrust Litigation248continuetofacemultidistrictlitigationaftertheU.S. District Court for theDistrictofRhodeIslanddeniedtheirmotiontodismiss.ThecourtfoundthatplaintiffpurchasersofLoestrin(abirthcontrolmedication)sufficientlypleadedtheirallegationsthatdefendantsenteredillegalreverse-paymentagreementstokeepgenericLoestrinoffthemarket,
butfreedtwoofdefendants’parentcompaniesfromthesuitforlackofdirectallegationsagainstthem.Notethatthesamecourthadpreviouslydismissedplaintiffs’claimsin2014,findingthatunderActavis,reversepaymentshavetobecashpaymentstobeconsideredillegal.Onappeal,theFirstCircuitvacatedthedismissalandremandedthecasebacktothedistrictcourt,findingthatthelowercourt’sinterpretationofActaviswastoostrictandthattheActavisprecedentappliestonon-cashpaymentsaswell.249 Alsoworthnotingisthatearlierin2017,theLoestrindefendantshadsuccessfullymovedtocompeldiscoveryregardingthemarketing,pricingandsalesofother oral contraceptives,arguingthatwhenevaluatingmonopolypower,therelevantmarketislargerthana“singledrugmarket”becauseotheroralcontraceptivesaretherapeuticallyinterchangeable.250
Other Generic Entry Issues
Product-Hopping
Fewfederalappellatecourtshaveaddressedwhetherallegationsthatabrand-namedrugmanufacturerengagedin“product-hopping”canconstituteaviolationoftheantitrustlaws.“Product-hopping”inthepharmaceuticalindustryreferstothestrategyofabrand-namedrugmanufacturertointroduceformulationchanges,modificationofdosage,orotheralterationsinordertoavoidcompetitionfromtypicallylower-pricedgenericdrugs.Becausegenericmanufacturersmustshowthattheirversionofthedrugandthecurrentlymarketedbrand-namedrugarebioequivalent(i.e.,haveasimilarformulationandeffect),abrandmanufacturer’salterationstoadrugcanforcegenericstoincurcostlydelaysindevelopmentandapproval(especiallywhendonejustpriortogenericentry).Typically,genericsareautomaticallysubstitutedforthemoreexpensivebrandversionbypharmacists,sobrandsare
incentivizedtodelaycompetitionforaslongaspossible.
Onlytwoappellatecourtshaveweighedinviafairlyrecentdecisions:theU.S.CourtofAppealsfortheSecondCircuit’sNamendadecisioninMay2015,251findingagainstthebrandeddefendant;andtheThirdCircuit’sMylandecisioninSeptember2016,252findinginfavorofthebrandeddefendant.SinceNamendaandMylan, 2017developmentsgenerallyaffirmthattheultimatesuccessofaproduct-hoppingclaimunderfederalantitrustlawsisahighlyfactualinquiry,onissuessuchaswhetherdefendant(s)engagedina“hardswitch”bydiscontinuingtheoldversionofthedrug,versusa“softswitch”bypushing,but not limiting, consumers tothenewversionofthedrugthroughaggressivemarketing.
In In Re Asacol Antitrust Litigation,253 theU.S.DistrictCourtfortheDistrict of Massachusetts’sdecisionhighlightstheimportanceof“hardswitch”evidencesupportingaproduct-hoppingclaim.There,directpurchasersofAsacolallegedthatbeforedefendantWarnerChilcott’spatentonthedrugexpired,WarnerChilcottproduct-hoppedfromAsacol(400mgtablet)toAsacolHD(800mgtablet)andlatertoDelzicol(400mgcapsuleenclosingtheAsacoltablet).ThecourtfoundtheplaintiffshadallegedsufficientfactssupportingtheirDelzicolproduct-hoppingclaimtosurviveWarnerChilcott’smotiontodismiss,butdismissedtheAsacolHDpieceoftheirclaim.Unlikedefendant’s“hardswitch”fromAsacoltoDelzicol,wheredefendantremovedAsacolfromthemarketshortlybeforeitspatentexpiredandgenericscouldenter,AsacolandAsacolHDwereonthemarketatthesametime.Notwithstandingtheplaintiffs’allegationsthatthedefendanthadencouragedconsumerstoswitchfromAsacoltoAsacolHDthrough“softswitch”marketingtactics,thecourtfoundthefact
WSGR 2017 Antitrust Year in Review
30
thatconsumersstillhadachoicebetweenthetwodrugsprecludedanyantitrustliability.
In In re Suboxone Antitrust Litigation,254 amultidistrictlitigationbeforetheU.S. DistrictCourtfortheEasternDistrictofPennsylvania,thecourtdenieddefendantMonoSol’srequesttotossaproduct-hoppingsuitbroughtbymorethan40states,finding(atthemotiontodismissstage)plausibleallegationsthatMonoSolviolatedantitrustlawsbydelayinggenericversionsofSuboxone(anopioidaddictiontreatment).
Asbackground,theFDAhadgrantedbranddrugmanufacturerIndivioraseven-yearmarketexclusivityafterIndiviorfirstlaunchedSuboxonetabletsin2002.TheplaintiffsallegethatIndivior’ssistercompanysignedanagreementwithMonoSoltodevelopandmarketadissolvablefilmversionofSuboxonethatwouldbeatthemarketentranceofgenerictablets,withtheintentofproduct-hoppingawayfromtabletstofilmandextendingIndivior’smarketexclusivityontheSuboxonefranchise.Thedefendantsallegedlyusedacombinationof“softswitch”(e.g.,marketingthefilmversionas“filmissafer”andpricingitlowertoincentivizeaswitchawayfromtabletsbyhealthcareproviders)and“hardswitch”(e.g.,announcingplantoremovetabletsfromthemarket)tacticsaspartoftheirproduct-hoppingscheme.IndenyingMonoSol’smotiontodismiss,theSuboxone courtfoundthat,atleastatthemotiontodismissstage,allegationsthatMonoSolsuggested“hardswitch”tacticstoIndiviorhelpedtheplaintiffscreateaplausibleinferencethatMonoSolparticipatedintheallegedconspiracy.255
Risk Evaluation and Mitigation Strategy (REMS)
TheIn re Suboxone court denied MonoSol’smotiontodismiss,inpartbecauseIndiviorallegedlydelayed
genericentrybyrefusingtocooperatewithgenericcompetitorsinfinalizingandsubmittingasharedRiskEvaluationandMitigationStrategy(REMS)totheFDA,notwithstandingthefactthattheFDAhadorderedIndiviortocooperateinasharedREMS.256
REMSaresafetyprotocolsthattheFDArequiresthemanufacturertoundertakeaspartoftheapprovalofparticulardrugs,likeSuboxone,thatposesubstantialrisktocertainpatientsandothersthathandlethedrug.Oftentheseprotocolscanincluderestricteddistribution,additionallabeling,orspecializedpatientmanagementdatabases.SharedREMS,likeindividualREMS,areusedtoaddresssafetyconcernsofpharmaceuticalproducts,butaredesignedtocoversituationswheremultiplemanufacturersaremarketingversionsofthesamedrug.
In2017,REMShasbeenoneareaofparticularfocusfortheFDA’seffortstoremoveregulatoryobstaclestogenericcompetitionandaccelerateconsumers’accesstogenericdrugs.WhentheFDA’snewworkinggroupofexpertsmetinAugust2017todiscussincreasinggenericcompetitionandmodernizingtheHatch-WaxmanAct,REMSwasoneoftheissuesthatcameupasneedingimprovement.TheconcernisthatREMSasitcurrentlystandsunnecessarilycomplicatestheFDAapprovalprocessforgenericdrugs.Forexample,underwhichgenericdrugmakersneedtoobtainsamplesfrombranddrugmanufacturerstoprovebioequivalence.FordrugsthataresubjecttoREMS,branddrugmanufacturerscouldarguethattheyarenotallowedtoprovidesuchsamplestotheirgenericcompetitors,orareboundbydistributionrestrictionsundertheREMS.
Moreover,theFDAcurrentlyencouragesbrandandgenericmanufacturerstonegotiateasharedREMS,andbrandmanufacturersoftenprolongthisnegotiationsotheyenjoymarketexclusivity
whilethenegotiationispending.257 CongresshasalsotakenactiontoimprovethecurrentREMSsystem.InApril2017,abipartisangroupofU.S.senatorsintroducedabillintendedtostreamlinethegenericdrugapprovalprocessthat,amongotherthings,allowsgenericdrugmakerstoparticipateinthebranddrug’sREMS.258
Citizen Petitions
Citizenpetitions,whichallowindividualsandorganizationstopetitiontheFDAtomakecertainchangestohealthpolicy,areanothermethodbywhichpharmaceuticalcompaniesallegedlyseektodelayorforeclosecompetition.InFebruary2017,theFTCfiledafirst-of-its-kindlawsuitpertainingto46publicfilings,including24citizenpetitions,thatViroPharmahassubmittedinrecentyearsconcerningasingleproduct.259AccordingtotheFTC,ViroPharmaabusedthecitizenpetitionprocesswithexcessivefilingsthatpurporttoraisescientificconcerns,butwerereallyintendedtodelaygenericversionsofitsbrand-namedrugVancocinfromenteringthemarket.AlthoughtheFDArejectsmostcitizenpetitions,thereviewandanalysisprocesscandiverttheagency’slimitedresourcesandpotentiallycausedelaysinapprovalofproducts.TheFTC,throughitslawsuithopestosignaltopharmaceuticalcompaniesthattheycannolongermanipulatethecitizenpetitionprocesstodelaygenericentrywithimpunity,markingamilestoneforongoingconcernsoverabusivecitizenpetitionsthatdatebackmorethanadecade.260
Sovereign Immunity
SeveralrecentdecisionsbytheUSPTOPatentTrialandAppealBoard(PTAB)indicatethatstateactorsenjoysovereignimmunityprotectionforpatentschallengedinthePTAB’sinter partesreviewprocess.Inabidtostaveoffgenericcompetitiontoitsdry-eyedrugRestasis,thedrugcompanyAllerganenteredadealwith
WSGR 2017 Antitrust Year in Review
31
theSaintRegisMohawkTribe,aNativeAmericantribeinupstateNewYork.Aspartofthedeal,Allergantransferreditspatentstothetribeandagreedtopaythetribe$13.75millionupfront;inexchange,thetribewouldclaimsovereignimmunityasgroundstodismissgenericdrugmakerMylan’schallengeofthepatents’validitybeforetheUSPTO,leasethepatentsbacktoAllergan,andreceive$15millioninannualroyaltiesaslongasthepatentsremainvalid.
ThisunorthodoxarrangementtriggeredCongressionalinvestigationsoonafter.TheHouseCommitteeonOversightandGovernmentReformsentaletterdatedOctober3,2017toAllergan’sCEO,demandingmoreinformationaboutitstransferofRestasispatentstothetribe,261 andU.S.SenatorClaireMcCaskilldraftedabillinresponseaswell.262AlsoinOctober2017,mereweeksafterAllergan’spatenttransfertothetribe,theU.S.DistrictCourtfortheEasternDistrictofTexasinvalidatedAllergan’sRestasispatentsongroundsthattheclaimsassertedbyAllerganareobvious.263
ClassCertificationClasscertificationhasbecomeacriticalstageofantitrustlawsuitsbecauseitisatthispointofthecasethatthescopeoftheclass—andrelatedly,potentialdamages—isdecided.Successindefeatingclasscertificationmaydrasticallyreducetheoverallexposureadefendanthasinaclassactioncase.Amongthekeydevelopmentsthisyearwere:(a)themotionsforclasscertificationthathavebeengrantedinaseriesofclassactionlitigationsagainstpharmaceuticalcompaniesconcerningpay-for-delayagreements;(b)thedecisionsdenyingmotionsforclasscertificationbyindirectpurchasersduetothefailuretoprovequestionsoflaworfactcommon
totheproposedclass;and(3)sharplydividedviewsfromvariouscircuitcourtsoverwhetherandhowtheplaintiffsmustdemonstrateascertainability.
Class Certification in Pay-for-Delay Cases
Plaintiffsinseveralpay-for-delaycaseswonclasscertificationsin2017.Bothdirectandend-userpurchasersoflidocainepainpatcheswonclasscertificationinamultidistrictantitrustlitigationbeforetheU.S. District Court forNorthernDistrictofCalifornia,aftertheplaintiffssuccessfullyprovedthatthedefendants’reverse-paymentsettlementallegedlyledtoclass-wideinjuriesintheformofinflatedcostsforlidocainepatches.264Directandend-userpurchasersalsowonclasscertificationinIn re Solodyn Antitrust Litigation,anotherpay-for-delaycasebeforetheU.S.DistrictCourtforMassachusetts.265Thesamecourtalsograntedclasscertificationtoend-payorplaintiffsinIn re Asacol Antitrust Litigation,acaseinwhichtheplaintiffsallegethatWarnerChilcottunlawfullyblockedcompetitionforitsAsacolfranchisebyproduct-hoppingandenteringpay-for-delayagreementswithapotentialcompetitor.266
Onecommonissuearguedintheselitigationswaswhethertheplaintiffssufficientlyprovedclass-widecommoninjuryordamagesattheclasscertificationstage.Thecourtsintheselitigationsfoundthattheplaintiffsusedreliableandstatisticallysoundmethodstoshowclass-wideinjuryandthattheproposedclassesshouldnotberejectedatthisstage(whichwouldeffectivelyendthelitigation),becausethedefendantswouldhavetheopportunitylatertochallengepotentialflawsindamagecalculationsorsubstantivemattersbeforethejury.
Indirect Plaintiffs’ Failure to Survive Class Certification
Indirectpurchaserscontinuetohavedifficultyinsatisfyingthetypicalityandpredominancerequirements,especiallyincasesinvolvingcomplicateddistributionchannelsandpricemechanisms.
OnFebruary9, 2017,theU.S.CourtofAppealsfortheThirdCircuitaffirmedtheU.S.DistrictCourtofDelaware’sdecisionin In re Class 8 Transmission Indirect Purchaser Antitrust Litigation,denyingamotionforclasscertificationduetotheproposedclass’sfailuretomeetadequacyandpredominancerequirements.267TheindirectpurchaserplaintiffsclaimedthatEatonCorporationenteredintoexclusivedealingagreementswithseveraltruckmanufacturerstomaintainitsmonopolypoweroverheavy-dutytrucktransmission.TheThirdCircuitagreedwiththedistrictcourtthattheplaintiffsfailedtoshowantitrustimpactwouldatleastbecapableofproofattrialbycommonevidence,andemphasizedthenecessitytoconductarigorousanalysisofplaintiffs’theoryofclass-wideimpactwithsufficientsalesdataonissuessuchasoverchargeandimpactofpass-throughcosts.268
Further,onApril12,2017,theU.S.DistrictCourtfortheNorthernDistrictofCaliforniadeniedmotionsforclasscertificationin In re Lithium-Ion Batteries Antitrust Litigation269bybothindirectanddirect270 purchasersallegingprice-fixingconspiracyamonglithium-ionbatterymanufacturers.Thedefendantschallengedtheabsenceofprerequisitessuchastypicalityandpredominance.Thoughthecourtfoundtheindirectpurchaserplaintiffs“havethesameorsimilarinjurybasedonthesameconduct,”271thecourtfoundthattheIllinois Bricknon-repealerstates’interestsinprecludinganationalindirectpurchaser
WSGR 2017 Antitrust Year in Review
32
classoutweighedotherinterests.272 As such,theproposednationalindirectpurchaserclasswasdenied.
Different Standards for Ascertainability Requirement
InadditiontotherequirementssetforthinRule23oftheFederalRulesofCivilProcedure,theU.S.CourtsofAppealfortheFirst,Third,Fourth,andEleventhCircuitsrequireplaintiffstoproveanadministrativelyfeasiblewayforthecourttoascertainwhatpersonsorentitiesmakeuptheproposedclass.Incontrast,theSecond,Sixth,Seventh,Eighth,andNinthCircuitshavedeclinedtoadoptadministrativefeasibilityasanindependentrequirement.
ThisCircuitCourtsplitwasondisplayin2017. In In re Domestic Drywall Antitrust
Litigation,JudgeBalysonoftheU.S.DistrictCourtfortheEasternDistrictofPennsylvaniadeniedclasscertificationtotheindirectpurchaserclass,findingthattheindirectpurchasersfailedtopresentareliableoradministrativelyfeasiblemethodforascertainingmembersoftheirclass,sincetheproposeddefinitioncoveredpurchasesdatingbackuptosixyearsandlikelyincludedmillionsofplaintiffssituatedacrossawidevarietyofconsumertypes(includinghomeowners,businessowners,residentialtenants,andcommercialtenants,andinvolvingresidentialhomes,commercialbuildings,andfactories).273 Further,thejudgenotedthattherewasnoevidenceof“proofofpurchase”provingthatindirectpurchaserspurchaseddrywallinanyoftheparticularstatesatissueorthatthepurchaseddrywallwasactuallymanufacturedbyadefendant.274
Bycontrast,theU.S.CourtofAppealsfortheNinthCircuitexplicitlydeclinedtoadoptadministrativefeasibilityasaclasscertificationrequirementin Briseno v. ConAgra Foods Inc.275There,theplaintiffsarguedthattheyweredeceivedormisledbyacookingoilmanufacturer’s“100%Natural”label.TheBriseno court clearlypointedoutthat,unlikesomeofitssisterappellatecourts,“[a]separateadministrativefeasibilityprerequisitetoclasscertificationisnotcompatiblewiththelanguageofRule23”intheNinthCircuit.276 BrisenoconfirmsthatthereappearstobeasplitwithintheU.S.federalappellatecourtsonwhetherascertainabilityisarequirementforclasscertification,whichcanhaveimportanteffectsonthefuturelitigationstrategyofputativeclassactionplaintiffs.
Weexpectthat2018willmirrorthispastyear’supwardtrendinantitrustlitigation,whichoftenfollowsontheheelsofgovernmentinvestigations.TheTrumpAdministration’stransitionattheantitrustagencieswillcontinue,asthereremainmultiplehigh-levelopenpositionsattheU.S.DepartmentofJusticeandtheFederalTradeCommissionthatawaitSenateconfirmationoranappointment.Aswedetailedinthisreport,thefirstsixmonthsof2018willbringahigh-profilemergerchallenge,theU.S.Supreme
Court’sdecisionsonwhethertohearinternationalprice-fixingandairlineantitrustcases,andacorporatecriminaltrialinthecapacitorscartelinvestigation.
ThiscomingyearwillbringnewchallengesandcontinuedchangeintheU.S.andglobally.Welookforwardtotheopportunitytocontinuetokeepourclientsandcolleaguesupdatedonthelatestdevelopments,particularlyasweexpectWSGR’santitrustattorneystocontinuetoplayasignificantroleinmattersofimportancethroughoutthe
year.WeinviteyoutocontactyourregularWSGRattorneyoranymemberofthefirm’santitrustpracticeforadditionalinformationonanyofthematters,trends,orcontroversiesdetailedinthisreport.
Inclosing,wewouldliketoacknowledgeandthankthepartners,attorneys,andstaffofWSGR’santitrustpracticeintheWashington,D.C.,NewYork,SanFrancisco,SiliconValley,andBrusselsoffices,fortheircontributionstothe2017 Antitrust Year in Review.
Conclusion:Outlookfor2018
WSGR 2017 Antitrust Year in Review
33
WSGR’santitrustattorneysareuniquelypositionedtoassistclientswithawiderangeofissues,fromday-to-daycounselingandcompliancetocrucialbet-the-companymatters.OuraccomplishedteamconsistentlyisrecognizedamongtheleadingantitrustpracticesworldwidebysuchsourcesasGlobal Competition Review, Chambers Global,andLaw360. Infact,Global Competition Review hailedthegroupas“perhapsthebestantitrustandcompetitionpracticeforhigh-techmattersintheworld,”while
Chambers USAcharacterizedthemas“adominantfirmformattersinvolvingthehi-techsphere,actingformanyofthemostprominenttechnologyfirms,”witha“deepanddiversebenchofoutstandingpractitioners.” BasedinNewYorkCity,Washington,D.C.,SanFrancisco,SiliconValley,andBrussels,ourhighlyregardedantitrustattorneysadviseclientswithrespecttomergersandacquisitions,criminalandcivilinvestigationsbygovernment
agencies,antitrustlitigation,andissuesinvolvingintellectualproperty,consumerprotection,andprivacy.Weadviseclientsonafullrangeofissues,includingpricing,distribution,verticalrestrictions,standard-settingactivities,jointventures,andpatentpooling.WorkingwithFortune100globalenterprisesaswellasventure-backedstart-upcompanies,ourattorneyshaveexpertiseinvirtuallyeverysignificantindustrysector,includingtechnology,media,healthcare,services,transportation,andmanufacturing.
To view the complete listing of endnotes for this report, please visit https://www.wsgr.com/PDFs/2018-antitrust-endnotes.pdf.
AboutWSGR’sAntitrustPractice
WSGR 2017 Antitrust Year in Review
34
WSGR 2017 Antitrust Year in Review
650PageMillRoad,PaloAlto,California94304-1050|Phone650-493-9300|Fax650-493-6811|www.wsgr.com
AustinBeijingBostonBrusselsHongKongLosAngelesNewYorkPaloAltoSanDiegoSanFranciscoSeattleShanghaiWashington,DCWilmington,DE
©2018WilsonSonsiniGoodrich&Rosati,ProfessionalCorporation.Allrightsreserved.